|
G |
Abcc9 |
ATP binding cassette subfamily C member 9 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of ABCC9 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 4:175,531,854...175,655,849
Ensembl chr 4:175,532,547...175,655,356
|
|
G |
Abhd2 |
abhydrolase domain containing 2, acylglycerol lipase |
increases expression |
EXP |
Phenylephrine results in increased expression of ABHD2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:133,217,403...133,298,564
Ensembl chr 1:133,217,375...133,299,061
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
multiple interactions affects response to substance increases phosphorylation |
EXP |
ABL1 protein affects the reaction [Phenylephrine promotes the reaction [BCAR1 protein binds to CRK protein]]; ABL1 protein affects the reaction [Phenylephrine promotes the reaction [CRK protein binds to WASL protein]]; ABL1 protein affects the reaction [Phenylephrine results in increased phosphorylation of BCAR1 protein] ABL1 protein affects the susceptibility to Phenylephrine Phenylephrine results in increased phosphorylation of ABL1 protein |
CTD |
PMID:17615370 |
|
NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065
|
|
G |
Abtb3 |
ankyrin repeat and BTB domain containing 3 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of ABTB3 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 7:18,035,151...18,310,718
Ensembl chr 7:18,036,083...18,310,834
|
|
G |
Acadm |
acyl-CoA dehydrogenase medium chain |
multiple interactions decreases expression |
EXP |
AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of ACADM mRNA]; dorsomorphin promotes the reaction [Phenylephrine results in decreased expression of ACADM mRNA] |
CTD |
PMID:19699196 |
|
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
|
|
G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
increases expression |
EXP |
Phenylephrine results in increased expression of ACAT2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
|
|
G |
Ace |
angiotensin I converting enzyme |
affects response to substance |
ISO |
ACE protein affects the susceptibility to Phenylephrine |
CTD |
PMID:18431347 |
|
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
increases expression |
EXP |
Phenylephrine results in increased expression of ACOT2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
|
|
G |
Acta1 |
actin, alpha 1, skeletal muscle |
multiple interactions increases expression |
ISO EXP |
[Phenylephrine co-treated with ADRA1B protein] results in increased expression of ACTA1 protein; [Phenylephrine co-treated with Isoproterenol] results in increased expression of ACTA1 mRNA; [Phenylephrine results in increased activity of ITPR2 protein] which results in increased expression of ACTA1 mRNA; ANGPT1 protein inhibits the reaction [Phenylephrine results in increased expression of ACTA1 mRNA]; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of ACTA1 mRNA] MAPK8IP1 protein inhibits the reaction [Phenylephrine results in increased expression of ACTA1 mRNA]; N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Phenylephrine results in increased expression of ACTA1 mRNA]; Prazosin inhibits the reaction [Phenylephrine results in increased expression of ACTA1 mRNA]; RGS2 protein inhibits the reaction [Phenylephrine results in increased expression of ACTA1 mRNA]; S100A6 protein inhibits the reaction [Phenylephrine results in increased expression of ACTA1 mRNA]; S100B protein inhibits the reaction [Phenylephrine results in increased expression of ACTA1 mRNA]; TGFB1I1 protein promotes the reaction [Phenylephrine results in increased expression of ACTA1 mRNA] |
CTD |
PMID:10642269 PMID:10710348 PMID:11230109 PMID:11499749 PMID:11513749 PMID:12435817 PMID:15201137 PMID:15652358 PMID:15795322 PMID:16513848 PMID:16517124 PMID:16556869 PMID:17592507 PMID:18502941 PMID:18701451 PMID:19540241 More...
|
|
NCBI chr19:51,883,709...51,886,735
Ensembl chr19:51,883,715...51,886,742
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions increases expression |
EXP |
MYOCD protein affects the reaction [Phenylephrine results in increased expression of ACTA2 mRNA] |
CTD |
PMID:16556869 PMID:18158353 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actr3 |
actin related protein 3 |
increases expression |
EXP |
Phenylephrine results in increased expression of ACTR3 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr13:36,800,739...36,843,837
Ensembl chr13:36,800,093...36,844,124
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
multiple interactions |
EXP |
ADAM17 protein affects the reaction [Phenylephrine results in increased cleavage of and results in increased secretion of EGF protein]; ADAM17 protein affects the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; ADAM17 protein affects the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:16760267 |
|
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
|
|
G |
Adcy5 |
adenylate cyclase 5 |
increases response to substance |
ISO |
ADCY5 protein results in increased susceptibility to Phenylephrine |
CTD |
PMID:12869393 |
|
NCBI chr11:65,471,612...65,618,877
Ensembl chr11:65,471,612...65,618,974
|
|
G |
Adhfe1 |
alcohol dehydrogenase, iron containing, 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of ADHFE1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:9,705,966...9,732,580
Ensembl chr 5:9,705,970...9,732,517
|
|
G |
Adm |
adrenomedullin |
multiple interactions decreases response to substance decreases expression decreases secretion increases expression |
EXP ISO |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of ADM mRNA; [Phenylephrine co-treated with Isoproterenol] results in increased expression of ADM protein; ADM protein inhibits the reaction [Phenylephrine results in increased expression of MYL2 mRNA]; ADM protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] ADM protein results in decreased susceptibility to Phenylephrine Phenylephrine results in decreased expression of ADM mRNA Phenylephrine results in decreased secretion of ADM protein Phenylephrine results in increased expression of ADM mRNA; Phenylephrine results in increased expression of ADM protein |
CTD |
PMID:11470465 PMID:15370692 PMID:17250927 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adora1 |
adenosine A1 receptor |
multiple interactions increases expression |
EXP |
1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [N(6)-cyclopentyladenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA1 mRNA]]; 1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [N(6)-cyclopentyladenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA1 protein]]; ADORA1 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; alpha,beta-methyleneadenosine 5'-diphosphate inhibits the reaction [Phenylephrine results in increased expression of ADORA1 mRNA]; alpha,beta-methyleneadenosine 5'-diphosphate inhibits the reaction [Phenylephrine results in increased expression of ADORA1 protein]; N(6)-cyclopentyladenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA1 mRNA]; N(6)-cyclopentyladenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA1 protein]; Prazosin inhibits the reaction [Phenylephrine results in increased expression of ADORA1 protein] Phenylephrine results in increased expression of ADORA1 mRNA; Phenylephrine results in increased expression of ADORA1 protein |
CTD |
PMID:19966059 |
|
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
|
|
G |
Adora2a |
adenosine A2a receptor |
multiple interactions increases expression |
EXP |
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA2A mRNA]; 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA2A protein]; 8-(3-chlorostyryl)caffeine inhibits the reaction [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA2A mRNA]]; 8-(3-chlorostyryl)caffeine inhibits the reaction [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA2A protein]]; ADORA2A protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; alpha,beta-methyleneadenosine 5'-diphosphate inhibits the reaction [Phenylephrine results in increased expression of ADORA2A mRNA]; alpha,beta-methyleneadenosine 5'-diphosphate inhibits the reaction [Phenylephrine results in increased expression of ADORA2A protein]; Prazosin inhibits the reaction [Phenylephrine results in increased expression of ADORA2A protein] Phenylephrine results in increased expression of ADORA2A mRNA; Phenylephrine results in increased expression of ADORA2A protein |
CTD |
PMID:19966059 |
|
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
|
|
G |
Adora3 |
adenosine A3 receptor |
multiple interactions increases expression |
EXP |
2,3-diethyl-4,5-dipropyl-6-phenylpyridine-3-thiocarboxylate-5-carboxylate inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA3 mRNA]]; 2,3-diethyl-4,5-dipropyl-6-phenylpyridine-3-thiocarboxylate-5-carboxylate inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA3 protein]]; ADORA3 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; alpha,beta-methyleneadenosine 5'-diphosphate inhibits the reaction [Phenylephrine results in increased expression of ADORA3 mRNA]; alpha,beta-methyleneadenosine 5'-diphosphate inhibits the reaction [Phenylephrine results in increased expression of ADORA3 protein]; N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA3 mRNA]; N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA3 protein]; Prazosin inhibits the reaction [Phenylephrine results in increased expression of ADORA3 protein] Phenylephrine results in increased expression of ADORA3 mRNA; Phenylephrine results in increased expression of ADORA3 protein |
CTD |
PMID:19966059 |
|
NCBI chr 2:193,352,759...193,392,946
Ensembl chr 2:193,388,713...193,392,357
|
|
G |
Adprhl1 |
ADP-ribosylhydrolase like 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of ADPRHL1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr16:76,283,186...76,315,075
Ensembl chr16:76,283,103...76,354,440
|
|
G |
Adra1a |
adrenoceptor alpha 1A |
multiple interactions affects response to substance affects binding increases response to substance affects activity increases activity |
ISO EXP |
5-methylurapidil inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased abundance of Calcium]; [Colforsin co-treated with 1-Methyl-3-isobutylxanthine] affects the reaction [[Phenylephrine binds to and results in increased activity of ADRA1A protein] which affects the transport of Potassium]; [KCND3 protein co-treated with ADRA1A protein] affects the susceptibility to Phenylephrine; [Phenylephrine binds to and results in increased activity of ADRA1A protein] which affects the abundance of Phosphatidylinositol 4,5-Diphosphate; [Phenylephrine binds to and results in increased activity of ADRA1A protein] which affects the transport of Potassium; [Phenylephrine co-treated with ADRA1A protein] results in increased phosphorylation of MAPK1 protein; [Phenylephrine co-treated with ADRA1A protein] results in increased phosphorylation of MAPK3 protein; [Phenylephrine results in increased activity of ADRA1A protein] which affects the transport of Potassium; [Phenylephrine results in increased activity of ADRA1A protein] which results in increased abundance of Calcium; carvedilol inhibits the reaction [[Phenylephrine co-treated with ADRA1A protein] results in increased phosphorylation of MAPK1 protein]; carvedilol inhibits the reaction [[Phenylephrine co-treated with ADRA1A protein] results in increased phosphorylation of MAPK3 protein]; carvedilol inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased abundance of Calcium]; KT 5720 inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in decreased transport of Potassium]; Phentolamine inhibits the reaction [[Phenylephrine co-treated with ADRA1A protein] results in increased phosphorylation of MAPK1 protein]; Phentolamine inhibits the reaction [[Phenylephrine co-treated with ADRA1A protein] results in increased phosphorylation of MAPK3 protein]; Phentolamine inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased abundance of Calcium]; Phenylephrine binds to and results in increased activity of ADRA1A protein; Phenylephrine results in decreased activity of [KCND3 protein alternative form co-treated with ADRA1A protein]; Prazosin inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in decreased transport of Potassium]; Ro 32-0432 inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in decreased transport of Potassium] ADRA1A protein affects the susceptibility to Phenylephrine Phenylephrine binds to ADRA1A protein ADRA1A protein results in increased susceptibility to Phenylephrine Phenylephrine affects the activity of ADRA1A protein 8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA1A protein]; [Phenylephrine affects the activity of ADRA1A protein] which affects the transport of Potassium; [Phenylephrine binds to and results in increased activity of ADRA1A protein] which results in increased transport of Calcium; [Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of EIF4EBP1 protein; [Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of MTOR protein; [Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of RPS6KB1 protein; [Phenylephrine results in increased activity of ADRA1A protein] which results in increased transport of Glucose; Calcium affects the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of EIF4EBP1 protein]; Calcium affects the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of MTOR protein]; Calcium affects the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of RPS6KB1 protein]; Ethanol inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of EIF4EBP1 protein]; Ethanol inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of MTOR protein]; Ethanol inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of RPS6KB1 protein]; GR 127935 promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA1A protein]; Granisetron promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA1A protein]; Lisuride promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA1A protein]; Methysergide promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA1A protein]; Phenylephrine binds to and results in increased activity of ADRA1A protein |
CTD |
PMID:8183249 PMID:11709419 PMID:12935885 PMID:15306222 PMID:15365637 PMID:15550506 PMID:15603588 PMID:15672411 PMID:16498073 PMID:16545797 PMID:18257748 PMID:19133277 PMID:19419905 PMID:19566752 PMID:20217639 More...
|
|
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
|
|
G |
Adra1b |
adrenoceptor alpha 1B |
affects response to substance increases response to substance multiple interactions decreases expression increases activity |
ISO EXP |
ADRA1B protein affects the susceptibility to Phenylephrine ADRA1B protein results in increased susceptibility to Phenylephrine [Phenylephrine co-treated with ADRA1B protein] results in decreased expression of ATP2A2 protein; [Phenylephrine co-treated with ADRA1B protein] results in decreased expression of NPY protein; [Phenylephrine co-treated with ADRA1B protein] results in increased expression of ACTA1 protein; [Phenylephrine co-treated with ADRA1B protein] results in increased expression of GRK2 protein; [Phenylephrine co-treated with ADRA1B protein] results in increased expression of NPPA protein 4-Aminopyridine inhibits the reaction [ADRA1B protein results in increased susceptibility to Phenylephrine]; ADRA1B protein affects the reaction [Phenylephrine results in decreased activity of TGM2 protein]; chlorethylclonidine inhibits the reaction [ADRA1B protein results in increased susceptibility to Phenylephrine]; Estradiol promotes the reaction [ADRA1B protein results in increased susceptibility to Phenylephrine] Phenylephrine results in decreased expression of ADRA1B mRNA; Phenylephrine results in decreased expression of ADRA1B protein Phenylephrine results in increased activity of ADRA1B protein [Phenylephrine co-treated with ADRA1B protein] results in increased phosphorylation of MAPK1 protein; [Phenylephrine co-treated with ADRA1B protein] results in increased phosphorylation of MAPK3 protein; [Phenylephrine results in increased activity of ADRA1B protein] which results in increased abundance of Calcium; carvedilol inhibits the reaction [[Phenylephrine co-treated with ADRA1B protein] results in increased phosphorylation of MAPK1 protein]; carvedilol inhibits the reaction [[Phenylephrine co-treated with ADRA1B protein] results in increased phosphorylation of MAPK3 protein]; carvedilol inhibits the reaction [[Phenylephrine results in increased activity of ADRA1B protein] which results in increased abundance of Calcium]; Phentolamine inhibits the reaction [[Phenylephrine co-treated with ADRA1B protein] results in increased phosphorylation of MAPK1 protein]; Phentolamine inhibits the reaction [[Phenylephrine co-treated with ADRA1B protein] results in increased phosphorylation of MAPK3 protein]; Phentolamine inhibits the reaction [[Phenylephrine results in increased activity of ADRA1B protein] which results in increased abundance of Calcium] |
CTD |
PMID:10801782 PMID:11499749 PMID:11693201 PMID:15306222 PMID:16498073 PMID:18257748 PMID:18480251 More...
|
|
NCBI chr10:28,255,025...28,373,418
Ensembl chr10:28,255,025...28,312,919
|
|
G |
Adra1d |
adrenoceptor alpha 1D |
affects response to substance increases response to substance multiple interactions affects binding increases activity |
ISO EXP |
ADRA1D protein affects the susceptibility to Phenylephrine ADRA1D affects the susceptibility to Phenylephrine ADRA1D protein results in increased susceptibility to Phenylephrine BMY 7378 inhibits the reaction [ADRA1D protein results in increased susceptibility to Phenylephrine]; Phenylephrine binds to and results in increased activity of ADRA1D protein [Phenylephrine co-treated with ADRA1D protein] results in increased phosphorylation of MAPK1 protein; [Phenylephrine co-treated with ADRA1D protein] results in increased phosphorylation of MAPK3 protein; [Phenylephrine results in increased activity of ADRA1D protein] which results in increased abundance of Calcium; carvedilol inhibits the reaction [[Phenylephrine co-treated with ADRA1D protein] results in increased phosphorylation of MAPK1 protein]; carvedilol inhibits the reaction [[Phenylephrine co-treated with ADRA1D protein] results in increased phosphorylation of MAPK3 protein]; carvedilol inhibits the reaction [[Phenylephrine results in increased activity of ADRA1D protein] which results in increased abundance of Calcium]; Phentolamine inhibits the reaction [[Phenylephrine co-treated with ADRA1D protein] results in increased phosphorylation of MAPK1 protein]; Phentolamine inhibits the reaction [[Phenylephrine co-treated with ADRA1D protein] results in increased phosphorylation of MAPK3 protein]; Phentolamine inhibits the reaction [[Phenylephrine results in increased activity of ADRA1D protein] which results in increased abundance of Calcium] Phenylephrine binds to ADRA1D protein |
CTD |
PMID:8183249 PMID:11901185 PMID:15306222 PMID:15493479 PMID:16371063 PMID:18257748 PMID:19566752 More...
|
|
NCBI chr 3:118,793,356...118,809,354
Ensembl chr 3:118,793,346...118,809,354
|
|
G |
Adra2a |
adrenoceptor alpha 2A |
multiple interactions |
ISO |
Brimonidine Tartrate promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA2A protein]; Phenylephrine promotes the reaction [Brimonidine Tartrate binds to and results in increased activity of ADRA2A protein]; Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Brimonidine Tartrate binds to and results in increased activity of ADRA2A protein]]; Yohimbine inhibits the reaction [Brimonidine Tartrate promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA2A protein]] |
CTD |
PMID:10742289 |
|
NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365
|
|
G |
Adra2b |
adrenoceptor alpha 2B |
affects response to substance multiple interactions |
ISO |
ADRA2B protein affects the susceptibility to Phenylephrine ADRA2B protein affects the susceptibility to [Phenylephrine co-treated with Acetylcholine] |
CTD |
PMID:16815979 |
|
NCBI chr 3:114,585,174...114,589,220
Ensembl chr 3:114,585,169...114,589,355
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
multiple interactions |
EXP |
[Fenoterol binds to and results in increased activity of ADRB2 protein] which results in decreased susceptibility to Phenylephrine; [Salmeterol Xinafoate binds to and results in increased activity of ADRB2 protein] which results in decreased susceptibility to Phenylephrine; [Terbutaline binds to and results in increased activity of ADRB2 protein] which results in decreased susceptibility to Phenylephrine; CGP 20712A inhibits the reaction [[Fenoterol binds to and results in increased activity of ADRB2 protein] which results in decreased susceptibility to Phenylephrine]; CGP 20712A inhibits the reaction [[Salmeterol Xinafoate binds to and results in increased activity of ADRB2 protein] which results in decreased susceptibility to Phenylephrine]; CGP 20712A inhibits the reaction [[Terbutaline binds to and results in increased activity of ADRB2 protein] which results in decreased susceptibility to Phenylephrine]; Pertussis Toxin promotes the reaction [[Salmeterol Xinafoate binds to and results in increased activity of ADRB2 protein] which results in decreased susceptibility to Phenylephrine]; Pertussis Toxin promotes the reaction [[Terbutaline binds to and results in increased activity of ADRB2 protein] which results in decreased susceptibility to Phenylephrine] |
CTD |
PMID:16474418 |
|
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Adrb3 |
adrenoceptor beta 3 |
multiple interactions increases response to substance |
ISO |
amibegron inhibits the reaction [ADRB3 protein results in increased susceptibility to Phenylephrine] |
CTD |
PMID:16022967 |
|
NCBI chr16:64,839,820...64,844,552
Ensembl chr16:64,841,788...64,844,552
|
|
G |
Agt |
angiotensinogen |
affects response to substance multiple interactions increases expression increases response to substance |
EXP ISO |
AGT protein affects the susceptibility to Phenylephrine [Phenylephrine results in increased expression of AGT protein] which results in increased activity of MMP2 protein; AGT protein promotes the reaction [Phenylephrine results in increased expression of FOS mRNA]; Losartan inhibits the reaction [[Phenylephrine results in increased expression of AGT protein] which results in increased activity of MMP2 protein]; PRKCZ protein affects the reaction [Phenylephrine results in increased expression of AGT mRNA] Phenylephrine results in increased expression of AGT mRNA; Phenylephrine results in increased expression of AGT protein AGT protein modified form promotes the reaction [Phenylephrine results in increased abundance of Inositol Phosphates]; carvedilol inhibits the reaction [AGT protein modified form promotes the reaction [Phenylephrine results in increased abundance of Inositol Phosphates]]; carvedilol inhibits the reaction [AGT protein modified form results in increased susceptibility to Phenylephrine]; irbesartan inhibits the reaction [AGT protein modified form results in increased susceptibility to Phenylephrine] |
CTD |
PMID:2298476 PMID:7900855 PMID:16251426 PMID:16794485 PMID:27094369 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
multiple interactions affects response to substance |
EXP ISO |
[CGP 42112A binds to and results in increased activity of AGTR2 protein] which affects the susceptibility to Phenylephrine; [PD 123319 binds to and results in decreased activity of AGTR2 protein] which affects the susceptibility to Phenylephrine AGTR2 protein affects the susceptibility to Phenylephrine |
CTD |
PMID:11714657 PMID:19151255 |
|
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
increases expression |
ISO |
Phenylephrine results in increased expression of AIFM1 protein |
CTD |
PMID:31605733 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Ak4 |
adenylate kinase 4 |
increases expression |
EXP |
Phenylephrine results in increased expression of AK4 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions affects phosphorylation increases phosphorylation |
ISO EXP |
Cyclosporine inhibits the reaction [Phenylephrine results in increased phosphorylation of AKT1 protein] Phenylephrine affects the phosphorylation of AKT1 protein GRK2 protein affects the reaction [Phenylephrine results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:10679475 PMID:18084315 PMID:28759639 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aldh18a1 |
aldehyde dehydrogenase 18 family, member A1 |
increases expression |
EXP |
Phenylephrine results in increased expression of ALDH18A1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:239,375,657...239,407,956
Ensembl chr 1:239,375,669...239,407,890
|
|
G |
Angpt1 |
angiopoietin 1 |
multiple interactions increases expression |
ISO |
ANGPT1 protein inhibits the reaction [Phenylephrine results in increased expression of ACTA1 mRNA]; ANGPT1 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; ANGPT1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; ANGPT1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA]; Phenylephrine affects the reaction [ANGPT1 protein results in increased expression of ILK protein] Phenylephrine results in increased expression of ANGPT1 mRNA; Phenylephrine results in increased expression of ANGPT1 protein |
CTD |
PMID:18502941 |
|
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
|
|
G |
Angptl4 |
angiopoietin-like 4 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of ANGPTL4 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Apoe |
apolipoprotein E |
affects response to substance |
ISO |
APOE protein affects the susceptibility to Phenylephrine |
CTD |
PMID:17899169 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Areg |
amphiregulin |
increases expression |
EXP |
Phenylephrine results in increased expression of AREG mRNA |
CTD |
PMID:18158353 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Arhgef12 |
Rho guanine nucleotide exchange factor 12 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of ARHGEF12 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 8:43,350,070...43,475,404
Ensembl chr 8:43,353,799...43,476,366
|
|
G |
Arrdc3 |
arrestin domain containing 3 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of ARRDC3 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
|
|
G |
Asb18 |
ankyrin repeat and SOCS box-containing 18 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of ASB18 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 9:90,531,350...90,595,953
Ensembl chr 9:90,531,596...90,595,848
|
|
G |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
increases expression |
EXP |
Phenylephrine results in increased expression of ASB4 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 4:33,506,992...33,544,630
Ensembl chr 4:33,506,992...33,544,630
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
increases expression |
EXP |
Phenylephrine results in increased expression of ASNS mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Atf5 |
activating transcription factor 5 |
increases expression |
EXP |
Phenylephrine results in increased expression of ATF5 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
|
|
G |
Atp1b1 |
ATPase Na+/K+ transporting subunit beta 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of ATP1B1 mRNA |
CTD |
PMID:11204457 |
|
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
multiple interactions decreases activity increases expression affects response to substance decreases expression |
ISO EXP |
[Phenylephrine co-treated with ADRA1B protein] results in decreased expression of ATP2A2 protein Phenylephrine results in decreased activity of ATP2A2 protein Phenylephrine results in increased expression of ATP2A2 mRNA ATP2A2 protein affects the susceptibility to Phenylephrine (+)-JQ1 compound inhibits the reaction [Phenylephrine results in decreased expression of ATP2A2 mRNA]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Phenylephrine results in increased expression of ATP2A2 protein]; [[Phenylephrine results in increased activity of SLC9A1 protein] which results in increased transport of Calcium] which results in increased expression of ATP2A2 protein; [Phenylephrine results in decreased expression of ATP2A2 protein] which results in decreased transport of Calcium; Prazosin inhibits the reaction [Phenylephrine results in decreased expression of ATP2A2 mRNA]; THRB protein affects the reaction [Phenylephrine results in decreased expression of ATP2A2 protein]; Triiodothyronine inhibits the reaction [Phenylephrine results in decreased expression of ATP2A2 mRNA] Phenylephrine results in decreased expression of ATP2A2 mRNA; Phenylephrine results in decreased expression of ATP2A2 protein |
CTD |
PMID:11499749 PMID:11577024 PMID:15795322 PMID:16236312 PMID:17287366 PMID:17592507 PMID:19244478 PMID:21952229 PMID:23939492 More...
|
|
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
|
|
G |
Atp2b4 |
ATPase plasma membrane Ca2+ transporting 4 |
increases response to substance |
ISO |
ATP2B4 protein results in increased susceptibility to Phenylephrine |
CTD |
PMID:12933703 |
|
NCBI chr13:45,156,137...45,255,292
Ensembl chr13:45,156,146...45,255,246
|
|
G |
Atp9a |
ATPase phospholipid transporting 9A (putative) |
increases expression |
EXP |
Phenylephrine results in increased expression of ATP9A mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 3:157,360,354...157,467,628
Ensembl chr 3:157,360,359...157,467,818
|
|
G |
Atxn1 |
ataxin 1 |
multiple interactions |
EXP |
Phenylephrine inhibits the reaction [Iodine-131 inhibits the reaction [PAFAH1B1 protein binds to ATXN1 protein]] |
CTD |
PMID:32278511 |
|
NCBI chr17:18,737,491...19,142,360
Ensembl chr17:18,737,533...19,142,360
|
|
G |
Auts2 |
activator of transcription and developmental regulator AUTS2 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of AUTS2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr12:24,104,187...25,194,123
Ensembl chr12:24,104,192...25,194,416
|
|
G |
Avp |
arginine vasopressin |
multiple interactions increases secretion |
EXP |
Adenosine Triphosphate promotes the reaction [Phenylephrine results in increased secretion of AVP protein]; bisindolylmaleimide I inhibits the reaction [[Phenylephrine co-treated with Adenosine Triphosphate] results in increased secretion of AVP protein]; Dactinomycin inhibits the reaction [[Phenylephrine co-treated with Adenosine Triphosphate] results in increased secretion of AVP protein]; Dexamethasone inhibits the reaction [Phenylephrine results in increased secretion of AVP protein]; pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [[Phenylephrine co-treated with Adenosine Triphosphate] results in increased secretion of AVP protein] |
CTD |
PMID:2271928 PMID:11102496 |
|
NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:117,793,457...117,795,425
|
|
G |
Avpi1 |
arginine vasopressin-induced 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of AVPI1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:240,930,236...240,936,154
Ensembl chr 1:240,930,236...240,936,154
|
|
G |
Bad |
BCL2-associated agonist of cell death |
increases expression |
ISO |
Phenylephrine results in increased expression of BAD protein |
CTD |
PMID:31605733 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bambi |
BMP and activin membrane-bound inhibitor |
increases expression |
EXP |
Phenylephrine results in increased expression of BAMBI mRNA |
CTD |
PMID:18158353 |
|
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
decreases expression multiple interactions increases expression |
EXP ISO |
Phenylephrine results in decreased expression of BAX protein PTHLH protein affects the reaction [Phenylephrine results in decreased expression of BAX protein] Phenylephrine results in increased expression of BAX protein |
CTD |
PMID:19910689 PMID:31605733 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcar1 |
BCAR1 scaffold protein, Cas family member |
multiple interactions increases phosphorylation |
EXP |
ABL1 protein affects the reaction [Phenylephrine promotes the reaction [BCAR1 protein binds to CRK protein]]; ABL1 protein affects the reaction [Phenylephrine results in increased phosphorylation of BCAR1 protein]; Phenylephrine promotes the reaction [BCAR1 protein binds to CRK protein] |
CTD |
PMID:17615370 |
|
NCBI chr19:39,679,215...39,713,907
Ensembl chr19:39,679,204...39,713,907
|
|
G |
Bckdha |
branched chain keto acid dehydrogenase E1 subunit alpha |
decreases expression |
EXP |
Phenylephrine results in decreased expression of BCKDHA mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:81,138,946...81,167,765
Ensembl chr 1:81,138,947...81,167,862
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions increases expression decreases expression |
EXP ISO |
BCL2 protein affects the reaction [Phenylephrine results in increased expression of TIMP1 protein]; Phenylephrine inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA]; Phenylephrine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 mRNA]; Phenylephrine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 protein]; PTHLH protein affects the reaction [Phenylephrine results in increased expression of BCL2 mRNA]; PTHLH protein affects the reaction [Phenylephrine results in increased expression of BCL2 protein] Phenylephrine results in increased expression of BCL2 mRNA; Phenylephrine results in increased expression of BCL2 protein Phenylephrine results in decreased expression of BCL2 protein |
CTD |
PMID:11042672 PMID:19910689 PMID:31605733 PMID:35979984 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions decreases expression |
EXP ISO |
Phenylephrine inhibits the reaction [Doxorubicin results in decreased expression of BCL2L1 mRNA]; Phenylephrine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2L1 mRNA]; Phenylephrine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2L1 protein] Phenylephrine results in decreased expression of BCL2L1 protein |
CTD |
PMID:11042672 PMID:31605733 PMID:35979984 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bdh1 |
3-hydroxybutyrate dehydrogenase 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of BDH1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr11:69,302,534...69,343,173
Ensembl chr11:69,302,534...69,337,671
|
|
G |
Bdh2 |
3-hydroxybutyrate dehydrogenase 2 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of BDH2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 2:223,702,410...223,723,076
Ensembl chr 2:223,702,412...223,723,072
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
affects response to substance increases expression |
ISO EXP |
BDKRB2 affects the susceptibility to Phenylephrine Phenylephrine results in increased expression of BDKRB2 mRNA |
CTD |
PMID:10614985 PMID:18158353 |
|
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
increases expression |
EXP |
Phenylephrine results in increased expression of BDNF mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
increases expression |
EXP |
phenylephrine increases expression of mRNA in neonatal rat cardiomyocytes |
RGD |
PMID:26873969 |
RGD:11526363 |
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
increases expression |
EXP |
phenylephrine increases expression of mRNA in neonatal rat cardiomyocytes |
RGD |
PMID:26873969 |
RGD:11526363 |
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
|
|
G |
Bmp7 |
bone morphogenetic protein 7 |
decreases expression increases expression |
EXP |
Phenylephrine results in decreased expression of BMP7 mRNA phenylephrine increases expression of mRNA in neonatal rat cardiomyocytes |
CTD RGD |
PMID:18158353 PMID:26873969 |
RGD:11526363 |
NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:161,516,462...161,716,788
|
|
G |
Bnip3l |
BCL2 interacting protein 3 like |
increases expression |
EXP |
Phenylephrine results in increased expression of BNIP3L mRNA |
CTD |
PMID:16291751 |
|
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
|
|
G |
Boll |
boule homolog, RNA binding protein |
decreases expression |
EXP |
Phenylephrine results in decreased expression of BOLL mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 9:56,734,890...56,859,917
Ensembl chr 9:56,733,584...56,859,916
|
|
G |
Brd4 |
bromodomain containing 4 |
multiple interactions increases expression |
EXP |
Phenylephrine promotes the reaction [BRD4 protein binds to NPPA promoter] Phenylephrine results in increased expression of BRD4 protein |
CTD |
PMID:23939492 |
|
NCBI chr 7:11,216,446...11,296,029
Ensembl chr 7:11,216,446...11,295,539
|
|
G |
Btg3 |
BTG anti-proliferation factor 3 |
increases expression |
EXP |
Phenylephrine results in increased expression of BTG3 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr11:17,030,156...17,046,069
Ensembl chr11:17,030,160...17,046,170
|
|
G |
Cabin1 |
calcineurin binding protein 1 |
multiple interactions |
EXP |
CABIN1 protein inhibits the reaction [Phenylephrine results in increased activity of PPP3CB protein]; CABIN1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; CABIN1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA protein]; CABIN1 protein promotes the reaction [Phenylephrine results in decreased expression of KCND2 mRNA]; CABIN1 protein promotes the reaction [Phenylephrine results in decreased expression of KCND2 protein] |
CTD |
PMID:10655507 PMID:17060317 |
|
NCBI chr20:12,893,314...13,015,357
Ensembl chr20:12,893,358...13,015,357
|
|
G |
Cadps |
calcium dependent secretion activator |
decreases expression |
EXP |
Phenylephrine results in decreased expression of CADPS mRNA |
CTD |
PMID:18158353 |
|
NCBI chr15:12,289,803...12,742,786
Ensembl chr15:12,290,262...12,742,779
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
affects response to substance |
ISO EXP |
CALCA protein affects the susceptibility to Phenylephrine |
CTD |
PMID:11728430 PMID:18055875 |
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Calcrl |
calcitonin receptor like receptor |
multiple interactions |
EXP |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of CALCRL mRNA |
CTD |
PMID:17250927 |
|
NCBI chr 3:69,428,348...69,525,910
Ensembl chr 3:69,430,120...69,525,910
|
|
G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
decreases expression |
EXP |
Phenylephrine results in decreased expression of CAMK2A mRNA |
CTD |
PMID:18158353 |
|
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
|
|
G |
Camk2d |
calcium/calmodulin-dependent protein kinase II delta |
multiple interactions |
EXP |
CAMK2D protein promotes the reaction [Phenylephrine results in increased activity of MAP3K5 protein] |
CTD |
PMID:15629441 |
|
NCBI chr 2:215,023,785...215,287,351
Ensembl chr 2:215,024,004...215,286,178
|
|
G |
Car1 |
carbonic anhydrase 1 |
decreases activity |
ISO |
Phenylephrine results in decreased activity of CA1 protein |
CTD |
PMID:28800181 |
|
NCBI chr 2:86,829,436...86,872,209
Ensembl chr 2:86,861,897...86,872,208
|
|
G |
Car2 |
carbonic anhydrase 2 |
increases expression decreases activity |
EXP ISO |
Phenylephrine results in increased expression of CAR2 mRNA; Phenylephrine results in increased expression of CAR2 protein Phenylephrine results in decreased activity of CA2 protein |
CTD |
PMID:17124262 PMID:28800181 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Car4 |
carbonic anhydrase 4 |
increases expression |
EXP |
Phenylephrine results in increased expression of CA4 protein |
CTD |
PMID:17124262 |
|
NCBI chr10:69,827,945...69,836,501
Ensembl chr10:69,827,945...69,836,501
|
|
G |
Casp2 |
caspase 2 |
affects activity |
ISO |
Phenylephrine affects the activity of CASP2 protein |
CTD |
PMID:31605733 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
EXP ISO |
Phenylephrine inhibits the reaction [Oxygen deficiency results in increased activity of CASP3 protein] Phenylephrine results in increased activity of CASP3 protein |
CTD |
PMID:11042672 PMID:31605733 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
affects activity |
ISO |
Phenylephrine affects the activity of CASP8 protein |
CTD |
PMID:31605733 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
Phenylephrine results in increased activity of CASP9 protein |
CTD |
PMID:31605733 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Casr |
calcium-sensing receptor |
multiple interactions |
EXP |
Phenylephrine inhibits the reaction [Spermine binds to and results in increased activity of CASR protein] |
CTD |
PMID:11071898 |
|
NCBI chr11:64,235,251...64,304,811
Ensembl chr11:64,235,251...64,304,811
|
|
G |
Cat |
catalase |
multiple interactions decreases expression |
EXP |
CAT protein inhibits the reaction [Phenylephrine results in decreased expression of MFN2 protein]; CAT protein inhibits the reaction [Phenylephrine results in increased expression of DNM1L protein]; CAT protein inhibits the reaction [Phenylephrine results in increased expression of FIS1 protein]; CAT protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; CAT protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein] Phenylephrine results in decreased expression of CAT protein |
CTD |
PMID:16513848 PMID:18171680 PMID:20886221 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cav1 |
caveolin 1 |
multiple interactions |
ISO |
Sodium, Dietary affects the reaction [CAV1 protein results in increased susceptibility to Phenylephrine] |
CTD |
PMID:18178722 |
|
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Cav3 |
caveolin 3 |
multiple interactions affects localization decreases response to substance |
ISO EXP |
CAV3 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 protein]; CAV3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; CAV3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein] Phenylephrine affects the localization of CAV3 protein CAV3 protein results in decreased susceptibility to Phenylephrine |
CTD |
PMID:12847114 PMID:19299911 |
|
NCBI chr 4:145,582,168...145,598,142
Ensembl chr 4:145,582,060...145,598,137
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases expression |
EXP |
4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid inhibits the reaction [Phenylephrine results in increased expression of CCL2 mRNA]; parthenolide inhibits the reaction [Phenylephrine results in increased expression of CCL2 mRNA] Phenylephrine results in increased expression of CCL2 mRNA; Phenylephrine results in increased expression of CCL2 protein |
CTD |
PMID:15721863 PMID:15728586 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl27 |
C-C motif chemokine ligand 27 |
increases expression |
EXP |
Phenylephrine results in increased expression of CCL27 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:56,941,402...56,948,511
Ensembl chr 5:56,941,402...56,948,506
|
|
G |
Ccn1 |
cellular communication network factor 1 |
multiple interactions increases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased expression of CCN1 mRNA]; calphostin C inhibits the reaction [Phenylephrine results in increased expression of CCN1 mRNA]; chelerythrine inhibits the reaction [Phenylephrine results in increased expression of CCN1 mRNA] Phenylephrine results in increased expression of CCN1 mRNA; Phenylephrine results in increased expression of CCN1 protein |
CTD |
PMID:15117851 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccn2 |
cellular communication network factor 2 |
increases expression |
EXP |
Phenylephrine results in increased expression of CCN2 mRNA; Phenylephrine results in increased expression of CCN2 protein |
CTD |
PMID:15276029 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions increases expression |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased expression of CCND1 protein] |
CTD |
PMID:12163013 PMID:15603588 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
increases expression |
EXP |
Phenylephrine results in increased expression of CCND2 protein |
CTD |
PMID:12163013 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccnd3 |
cyclin D3 |
multiple interactions increases expression |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased expression of CCND3 protein] |
CTD |
PMID:12163013 |
|
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
|
|
G |
Ccnt1 |
cyclin T1 |
multiple interactions |
EXP |
Phenylephrine inhibits the reaction [HEXIM1 protein binds to CCNT1 protein] |
CTD |
PMID:17459355 |
|
NCBI chr 7:129,687,146...129,718,080
Ensembl chr 7:129,691,209...129,717,871
|
|
G |
Cd200 |
Cd200 molecule |
decreases expression |
EXP |
Phenylephrine results in decreased expression of CD200 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr11:55,410,166...55,437,527
Ensembl chr11:55,410,196...55,501,648
|
|
G |
Cdh2 |
cadherin 2 |
increases expression |
EXP |
Phenylephrine results in increased expression of CDH2 protein |
CTD |
PMID:17526999 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
increases expression |
EXP |
Phenylephrine results in increased expression of CDK2 protein |
CTD |
PMID:15603588 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
increases expression |
EXP |
Phenylephrine results in increased expression of CDK4 protein |
CTD |
PMID:15603588 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression increases stability |
ISO EXP |
Phenylephrine results in increased expression of CDKN1A mRNA; Phenylephrine results in increased expression of CDKN1A protein Phenylephrine results in increased stability of CDKN1A mRNA |
CTD |
PMID:10766810 PMID:15603588 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression |
EXP |
Phenylephrine results in increased expression of CDKN1B |
CTD |
PMID:15603588 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
decreases expression |
EXP |
Phenylephrine results in decreased expression of CEBPA mRNA |
CTD |
PMID:19443575 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cftr |
CF transmembrane conductance regulator |
multiple interactions |
EXP |
[Phenylephrine co-treated with 5-butyl-6-hydroxy-10-chlorobenzo(c)quinolizinium chloride] results in increased activity of CFTR protein; [Phenylephrine co-treated with 6-hydroxy-10-chlorobenzo(c)quinolizinium] results in increased activity of CFTR protein; Glyburide inhibits the reaction [[Phenylephrine co-treated with 5-butyl-6-hydroxy-10-chlorobenzo(c)quinolizinium chloride] results in increased activity of CFTR protein] |
CTD |
PMID:17596272 |
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Chchd6 |
coiled-coil-helix-coiled-coil-helix domain containing 6 |
increases expression |
EXP |
Phenylephrine results in increased expression of CHCHD6 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 4:121,803,501...122,024,209
Ensembl chr 4:121,792,717...122,024,216
|
|
G |
Clic2 |
chloride intracellular channel 2 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of CLIC2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr20:149,337...164,375
Ensembl chr20:148,907...164,355
|
|
G |
Clic4 |
chloride intracellular channel 4 |
increases expression |
EXP |
Phenylephrine results in increased expression of CLIC4 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:147,453,702...147,513,455
Ensembl chr 5:147,453,712...147,513,452
|
|
G |
Clu |
clusterin |
increases expression |
EXP |
Phenylephrine results in increased expression of CLU mRNA; Phenylephrine results in increased expression of CLU protein |
CTD |
PMID:19443575 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Cnn1 |
calponin 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of CNN1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 8:20,632,434...20,641,097
Ensembl chr 8:20,632,338...20,641,098
|
|
G |
Col18a1 |
collagen type XVIII alpha 1 chain |
decreases expression |
EXP |
Phenylephrine results in decreased expression of COL18A1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
|
|
G |
Colec12 |
collectin sub-family member 12 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of COLEC12 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618
|
|
G |
Corin |
corin, serine peptidase |
increases expression |
EXP |
Phenylephrine results in increased expression of CORIN mRNA |
CTD |
PMID:15191894 |
|
NCBI chr14:35,680,601...35,910,703
Ensembl chr14:35,681,304...35,909,503
|
|
G |
Cox11 |
cytochrome c oxidase copper chaperone COX11 |
decreases expression multiple interactions |
EXP |
Phenylephrine results in decreased expression of COX11 protein Copper Sulfate inhibits the reaction [Phenylephrine results in decreased expression of COX11 protein]; periodate-oxidized adenosine inhibits the reaction [Phenylephrine results in decreased expression of COX11 protein]; VEGFA protein inhibits the reaction [Phenylephrine results in decreased expression of COX11 protein] |
CTD |
PMID:23818984 PMID:25107896 |
|
NCBI chr10:75,458,735...75,465,322
Ensembl chr10:75,458,749...75,465,322
|
|
G |
Cox17 |
cytochrome c oxidase copper chaperone COX17 |
multiple interactions decreases expression |
EXP |
Copper Sulfate inhibits the reaction [Phenylephrine results in decreased expression of COX17 protein]; periodate-oxidized adenosine inhibits the reaction [Phenylephrine results in decreased expression of COX17 protein]; VEGFA protein inhibits the reaction [Phenylephrine results in decreased expression of COX17 protein] |
CTD |
PMID:23818984 PMID:25107896 |
|
NCBI chr11:62,400,733...62,406,507
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4i1 |
decreases expression multiple interactions |
EXP |
Phenylephrine results in decreased expression of COX4I1 protein Copper Sulfate inhibits the reaction [Phenylephrine results in decreased expression of COX4I1 protein]; periodate-oxidized adenosine inhibits the reaction [Phenylephrine results in decreased expression of COX4I1 protein] |
CTD |
PMID:23818984 |
|
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
|
|
G |
Cpt1b |
carnitine palmitoyltransferase 1B |
multiple interactions increases expression decreases expression |
EXP |
4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid inhibits the reaction [Phenylephrine results in decreased expression of CPT1B mRNA]; AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of CPT1B mRNA]; AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of CPT1B protein]; dorsomorphin promotes the reaction [Phenylephrine results in decreased expression of CPT1B mRNA]; dorsomorphin promotes the reaction [Phenylephrine results in decreased expression of CPT1B protein] Phenylephrine results in increased expression of CPT1B mRNA Phenylephrine results in decreased expression of CPT1B mRNA; Phenylephrine results in decreased expression of CPT1B protein |
CTD |
PMID:11879187 PMID:15721863 PMID:19699196 |
|
NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
EXP |
adenosine-3',5'-cyclic phosphorothioate inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of CREB1 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of CREB1 protein]; Phenylephrine promotes the reaction [CREB1 protein binds to CREBBP protein]; Phenylephrine results in increased phosphorylation of and results in increased activity of CREB1 protein; Prazosin inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of CREB1 protein]; Propranolol inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of CREB1 protein]; Ro 31-8220 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of CREB1 protein]; RPS6KA5 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of CREB1 protein] |
CTD |
PMID:14741741 PMID:15522277 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crebbp |
CREB binding protein |
multiple interactions increases response to substance |
EXP |
[Phenylephrine results in increased activity of CREBBP protein] which results in increased expression of NPPA protein; CREBBP protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; Phenylephrine promotes the reaction [CREB1 protein binds to CREBBP protein]; Phenylephrine promotes the reaction [NR3C2 protein binds to CREBBP protein]; Phenylephrine results in increased expression of and results in increased localization of CREBBP protein; Phenylephrine results in increased phosphorylation of and results in increased activity of CREBBP protein CREBBP protein results in increased susceptibility to Phenylephrine |
CTD |
PMID:11705990 PMID:12477714 PMID:15006641 PMID:15522277 PMID:19966502 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Crem |
cAMP responsive element modulator |
increases expression |
EXP |
Phenylephrine results in increased expression of CREM mRNA |
CTD |
PMID:12791704 PMID:18158353 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Crk |
CRK proto-oncogene, adaptor protein |
multiple interactions |
EXP |
ABL1 protein affects the reaction [Phenylephrine promotes the reaction [BCAR1 protein binds to CRK protein]]; ABL1 protein affects the reaction [Phenylephrine promotes the reaction [CRK protein binds to WASL protein]]; Phenylephrine promotes the reaction [BCAR1 protein binds to CRK protein] |
CTD |
PMID:17615370 |
|
NCBI chr10:60,530,469...60,556,703
Ensembl chr10:60,530,464...60,553,406
|
|
G |
Csnk2a1 |
casein kinase 2 alpha 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of CSNK2A1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
increases expression |
EXP |
Phenylephrine results in increased expression of CSPG4 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
|
|
G |
Csrp2 |
cysteine and glycine-rich protein 2 |
increases expression |
EXP |
Phenylephrine results in increased expression of CSRP2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 7:46,349,109...46,367,743
Ensembl chr 7:46,348,686...46,367,745
|
|
G |
Csrp3 |
cysteine and glycine rich protein 3 |
increases localization |
EXP |
Phenylephrine results in increased localization of CSRP3 protein |
CTD |
PMID:19376126 |
|
NCBI chr 1:98,528,067...98,546,647
Ensembl chr 1:98,528,068...98,546,653
|
|
G |
Cth |
cystathionine gamma-lyase |
increases activity |
EXP |
Phenylephrine results in increased activity of CTH protein |
CTD |
PMID:18184479 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
EXP |
Phenylephrine promotes the reaction [CTNNB1 protein binds to NPPA promoter] |
CTD |
PMID:19799869 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctsc |
cathepsin C |
decreases expression |
EXP |
Phenylephrine results in decreased expression of CTSC mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:142,028,386...142,059,841
Ensembl chr 1:142,028,392...142,060,387
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of CXCL1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of CXCL10 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl11 |
C-X-C motif chemokine ligand 11 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of CXCL11 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
|
|
G |
Cxxc4 |
CXXC finger protein 4 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of CXXC4 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 2:222,664,148...222,689,365
Ensembl chr 2:222,664,771...222,689,365
|
|
G |
Cyp11b3 |
cytochrome P450, family 11, subfamily b, polypeptide 3 |
increases expression |
EXP |
Phenylephrine results in increased expression of CYP11B2 mRNA |
CTD |
PMID:19966502 |
|
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
EXP |
Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]; Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]] |
CTD |
PMID:16510159 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of CYP26B1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
multiple interactions affects response to substance increases response to substance |
EXP |
20-hydroxy-5,8,11,14-eicosatetraenoic acid affects the reaction [CYP4A1 protein affects the susceptibility to Phenylephrine]; 20-hydroxy-5,8,11,14-eicosatetraenoic acid inhibits the reaction [DDMS inhibits the reaction [CYP4A1 protein results in increased susceptibility to Phenylephrine]]; 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid inhibits the reaction [CYP4A1 protein results in increased susceptibility to Phenylephrine]; DDMS inhibits the reaction [CYP4A1 protein results in increased susceptibility to Phenylephrine] |
CTD |
PMID:11124159 PMID:12388396 |
|
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
increases expression |
EXP |
Phenylephrine results in increased expression of CYP51 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
|
|
G |
Dapk1 |
death associated protein kinase 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of DAPK1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
|
|
G |
Dgke |
diacylglycerol kinase epsilon |
multiple interactions |
ISO |
DGKE protein inhibits the reaction [Phenylephrine results in increased abundance of Diglycerides]; DGKE protein inhibits the reaction [Phenylephrine results in increased localization of PRKCA protein]; DGKE protein inhibits the reaction [Phenylephrine results in increased localization of PRKCE protein] |
CTD |
PMID:18487437 |
|
NCBI chr10:73,853,030...73,877,334
Ensembl chr10:73,855,583...73,877,100
|
|
G |
Dgkz |
diacylglycerol kinase zeta |
multiple interactions |
ISO |
DGKZ protein inhibits the reaction [Phenylephrine results in increased abundance of Diglycerides]; DGKZ protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] |
CTD |
PMID:16380548 |
|
NCBI chr 3:77,904,149...77,946,114
Ensembl chr 3:77,904,150...77,946,099
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
increases expression |
EXP |
Phenylephrine results in increased expression of DHCR7 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dio2 |
iodothyronine deiodinase 2 |
increases activity increases expression |
EXP |
Phenylephrine results in increased activity of DIO2 protein Phenylephrine results in increased expression of DIO2 mRNA |
CTD |
PMID:15345674 |
|
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
|
|
G |
Dnah12 |
dynein, axonemal, heavy chain 12 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of DNAH12 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr16:1,936,354...2,092,663
Ensembl chr16:1,937,817...2,092,664
|
|
G |
Dnajb5 |
DnaJ heat shock protein family (Hsp40) member B5 |
increases expression |
EXP |
Phenylephrine results in increased expression of DNAJB5 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:57,176,840...57,186,067
Ensembl chr 5:57,176,845...57,185,490
|
|
G |
Dnm1l |
dynamin 1-like |
increases expression multiple interactions |
EXP |
Phenylephrine results in increased expression of DNM1L protein CAT protein inhibits the reaction [Phenylephrine results in increased expression of DNM1L protein]; N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Phenylephrine results in increased expression of DNM1L protein]; sanglifehrin A inhibits the reaction [Phenylephrine results in increased expression of DNM1L protein] |
CTD |
PMID:20886221 |
|
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
|
|
G |
Dpt |
dermatopontin |
decreases expression |
EXP |
Phenylephrine results in decreased expression of DPT mRNA |
CTD |
PMID:18158353 |
|
NCBI chr13:77,123,224...77,151,646
Ensembl chr13:77,123,115...77,151,639
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of DUSP1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
multiple interactions |
EXP |
DUSP6 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of EIF4EBP1 protein]; DUSP6 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; DUSP6 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; DUSP6 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:15757502 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
E2f3 |
E2F transcription factor 3 |
increases expression |
EXP |
Phenylephrine results in increased expression of E2F3 protein |
CTD |
PMID:12682052 |
|
NCBI chr17:34,601,756...34,679,139
Ensembl chr17:34,601,830...34,676,253
|
|
G |
E2f4 |
E2F transcription factor 4 |
increases expression |
EXP |
Phenylephrine results in increased expression of E2F4 protein |
CTD |
PMID:12682052 |
|
NCBI chr19:33,174,396...33,181,806
Ensembl chr19:33,174,410...33,181,806
|
|
G |
E2f5 |
E2F transcription factor 5 |
increases expression |
EXP |
Phenylephrine results in increased expression of E2F5 protein |
CTD |
PMID:12682052 |
|
NCBI chr 2:86,997,331...87,012,908
Ensembl chr 2:86,997,332...87,012,990
|
|
G |
Ece1 |
endothelin converting enzyme 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of ECE1 mRNA |
CTD |
PMID:15007106 |
|
NCBI chr 5:150,077,679...150,179,375
Ensembl chr 5:150,077,644...150,179,371
|
|
G |
Ecm1 |
extracellular matrix protein 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of ECM1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 2:183,287,491...183,292,729
Ensembl chr 2:183,287,322...183,292,671
|
|
G |
Edf1 |
endothelial differentiation-related factor 1 |
multiple interactions affects response to substance increases expression |
EXP |
MBF1 protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein] MBF1 protein affects the susceptibility to Phenylephrine Phenylephrine results in increased expression of MBF1 |
CTD |
PMID:12729799 |
|
NCBI chr 3:8,377,058...8,381,363
Ensembl chr 3:8,366,613...8,381,363
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions increases expression increases response to substance |
ISO EXP |
EP300 protein promotes the reaction [[Phenylephrine results in increased activity of GATA4 protein] which results in increased expression of EDN1 mRNA] Phenylephrine results in increased expression of EDN1 mRNA; Phenylephrine results in increased expression of EDN1 protein EDN1 protein results in increased susceptibility to Phenylephrine Phenylephrine promotes the reaction [GATA4 protein binds to EDN1 promoter]; Polyphenols inhibits the reaction [EDN1 protein results in increased susceptibility to Phenylephrine]; Prazosin inhibits the reaction [Phenylephrine results in increased expression of EDN1 protein]; Y 27632 inhibits the reaction [Phenylephrine results in increased expression of EDN1 mRNA]; ZFPM2 protein inhibits the reaction [Phenylephrine results in increased expression of EDN1 mRNA] |
CTD |
PMID:10788492 PMID:11739382 PMID:12724418 PMID:15007106 PMID:15220332 PMID:20977430 More...
|
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Ednra |
endothelin receptor type A |
multiple interactions |
EXP |
[cyclo(Trp-Asp-Pro-Val-Leu) binds to and results in decreased activity of EDNRA protein] which results in decreased susceptibility to Phenylephrine; phosphoramidon inhibits the reaction [Phenylephrine results in increased expression of EDNRA protein] |
CTD |
PMID:15007106 |
|
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
|
|
G |
Ednrb |
endothelin receptor type B |
increases expression |
EXP |
Phenylephrine results in increased expression of EDNRB protein |
CTD |
PMID:15007106 |
|
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
EXP |
[EGF protein binds to EGFR protein] promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; [EGF protein binds to EGFR protein] promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; ADAM17 protein affects the reaction [Phenylephrine results in increased cleavage of and results in increased secretion of EGF protein]; Phenylephrine results in increased cleavage of and results in increased secretion of EGF protein |
CTD |
PMID:16760267 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions increases phosphorylation |
ISO EXP |
Atorvastatin inhibits the reaction [Phenylephrine results in increased expression of and results in increased phosphorylation of and results in increased activity of EGFR protein]; Phenylephrine results in increased expression of and results in increased phosphorylation of and results in increased activity of EGFR protein [EGF protein binds to EGFR protein] promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; [EGF protein binds to EGFR protein] promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein] Phenylephrine results in increased phosphorylation of EGFR protein |
CTD |
PMID:14676212 PMID:16760267 PMID:18360054 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
increases expression |
EXP |
Phenylephrine results in increased expression of EGLN3 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions increases expression |
ISO EXP |
EGR1 protein affects the reaction [[Isoproterenol co-treated with Phenylephrine] results in increased expression of SLC8A1 mRNA]; EGR1 protein affects the reaction [[Isoproterenol co-treated with Phenylephrine] results in increased expression of SLC8A1 protein]; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of ACTA1 mRNA]; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of JUN mRNA]; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of NAB2 mRNA]; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of NPPA mRNA]; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of SP1 mRNA] Phenylephrine promotes the reaction [EGR1 protein binds to FGF2 promoter] Phenylephrine results in increased expression of EGR1; Phenylephrine results in increased expression of EGR1 mRNA |
CTD |
PMID:7905536 PMID:10710348 PMID:10779383 PMID:15621046 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
multiple interactions increases phosphorylation |
EXP |
CGP 57380 inhibits the reaction [Phenylephrine results in increased phosphorylation of EIF4E protein]; Sirolimus inhibits the reaction [Phenylephrine results in increased phosphorylation of EIF4E protein]; U 0126 inhibits the reaction [Phenylephrine results in increased phosphorylation of EIF4E protein] |
CTD |
PMID:15757502 |
|
NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
multiple interactions increases phosphorylation |
EXP |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Phenylephrine results in increased phosphorylation of EIF4EBP1 protein]; [Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of EIF4EBP1 protein; bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased phosphorylation of EIF4EBP1 protein]; Calcium affects the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of EIF4EBP1 protein]; DUSP6 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of EIF4EBP1 protein]; Ethanol inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of EIF4EBP1 protein]; rottlerin inhibits the reaction [Phenylephrine results in increased phosphorylation of EIF4EBP1 protein]; Sirolimus inhibits the reaction [Phenylephrine results in increased phosphorylation of EIF4EBP1 protein]; U 0126 inhibits the reaction [Phenylephrine results in increased phosphorylation of EIF4EBP1 protein] |
CTD |
PMID:12411397 PMID:12720544 PMID:12935885 PMID:15757502 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
multiple interactions increases expression increases phosphorylation |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased expression of ELK1 mRNA]; MAPK1 protein affects the reaction [Phenylephrine results in increased expression of ELK1 mRNA]; MAPK3 protein affects the reaction [Phenylephrine results in increased expression of ELK1 mRNA]; Phenylephrine promotes the reaction [ELK1 protein modified form binds to FOS promoter] Phenylephrine results in increased phosphorylation of ELK1 protein |
CTD |
PMID:10900171 |
|
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Elovl5 |
ELOVL fatty acid elongase 5 |
increases expression |
EXP |
Phenylephrine results in increased expression of ELOVL5 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 8:78,790,846...78,857,307
Ensembl chr 8:78,790,846...78,857,284
|
|
G |
Eno2 |
enolase 2 |
increases expression |
EXP |
Phenylephrine results in increased expression of ENO2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Eno3 |
enolase 3 |
increases expression |
EXP |
Phenylephrine results in increased expression of ENO3 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr10:55,370,531...55,375,921
Ensembl chr10:55,366,975...55,375,921
|
|
G |
Ep300 |
E1A binding protein p300 |
multiple interactions increases response to substance increases expression |
ISO EXP |
EP300 protein promotes the reaction [[Phenylephrine results in increased activity of GATA4 protein] which results in increased expression of EDN1 mRNA] EP300 protein results in increased susceptibility to Phenylephrine 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased expression of EP300 mRNA]; [Phenylephrine results in increased activity of EP300 protein] which results in increased expression of NPPA protein; [SIRT6 protein co-treated with EP300 protein] affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; [SIRT6 protein co-treated with EP300 protein] affects the reaction [Phenylephrine results in increased expression of NPPB mRNA]; anacardic acid inhibits the reaction [Phenylephrine results in increased expression of EP300 protein]; EP300 protein affects the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; EP300 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; EP300 protein affects the reaction [Phenylephrine results in increased expression of NPPB mRNA]; EP300 protein promotes the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; MAPK1 protein promotes the reaction [Phenylephrine results in increased expression of EP300 mRNA]; Phenylephrine promotes the reaction [EP300 protein binds to NPPA promoter]; Phenylephrine promotes the reaction [GATA4 protein binds to EP300 protein]; Phenylephrine results in increased phosphorylation of and results in increased activity of EP300 protein; Resveratrol inhibits the reaction [Phenylephrine promotes the reaction [EP300 protein binds to NPPA promoter]]; Resveratrol inhibits the reaction [Phenylephrine results in increased expression of EP300 protein]; SIRT6 protein inhibits the reaction [Phenylephrine results in increased expression of EP300 protein]; ZFPM2 protein inhibits the reaction [Phenylephrine promotes the reaction [GATA4 protein binds to EP300 protein]] Phenylephrine results in increased expression of EP300 mRNA; Phenylephrine results in increased expression of EP300 protein |
CTD |
PMID:11705990 PMID:12477714 PMID:12724418 PMID:15006641 PMID:15220332 PMID:15593114 PMID:23297412 PMID:27094368 More...
|
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of EPAS1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Epb41l4b |
erythrocyte membrane protein band 4.1 like 4B |
increases expression |
EXP |
Phenylephrine results in increased expression of EPB41L4B mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:71,691,706...71,852,583
Ensembl chr 5:71,694,331...71,851,990
|
|
G |
Epha4 |
Eph receptor A4 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of EPHA4 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 9:78,815,460...78,958,139
Ensembl chr 9:78,815,460...78,958,139
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of EPHX2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
ESR1 protein affects the susceptibility to [Lipopolysaccharides co-treated with Phenylephrine co-treated with Acetylcholine]; ESR1 protein affects the susceptibility to [Lipopolysaccharides co-treated with Phenylephrine co-treated with Nitroprusside]; ESR1 protein affects the susceptibility to [Lipopolysaccharides co-treated with Phenylephrine] |
CTD |
PMID:17158209 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Eya2 |
EYA transcriptional coactivator and phosphatase 2 |
multiple interactions |
EXP |
EYA2 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 protein]; EYA2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA protein] |
CTD |
PMID:17327491 |
|
NCBI chr 3:154,335,598...154,519,006
Ensembl chr 3:154,335,400...154,518,793
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of FABP4 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fads3 |
fatty acid desaturase 3 |
increases expression |
EXP |
Phenylephrine results in increased expression of FADS3 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:206,685,667...206,702,538
Ensembl chr 1:206,685,894...206,704,769
|
|
G |
Fam110b |
family with sequence similarity 110, member B |
decreases expression |
EXP |
Phenylephrine results in decreased expression of FAM110B mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:18,789,362...18,929,647
Ensembl chr 5:18,789,389...18,929,828
|
|
G |
Fbn1 |
fibrillin 1 |
multiple interactions |
ISO |
FBN1 protein affects the reaction [Phenylephrine results in increased secretion of Epoprostenol metabolite]; FBN1 protein affects the reaction [Phenylephrine results in increased secretion of Thromboxane A2 metabolite]; FBN1 protein affects the reaction [PTGS1 protein affects the susceptibility to Phenylephrine] |
CTD |
PMID:17641673 |
|
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
|
|
G |
Fdx1 |
ferredoxin 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of FDX1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 8:52,268,536...52,287,344
Ensembl chr 8:52,268,536...52,287,414
|
|
G |
Fgf12 |
fibroblast growth factor 12 |
increases expression |
EXP |
Phenylephrine results in increased expression of FGF12 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr11:71,997,151...72,564,757
Ensembl chr11:71,997,099...72,562,607
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
increases expression |
EXP |
Phenylephrine results in increased expression of FGF18 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr10:17,706,011...17,737,702
Ensembl chr10:17,706,174...17,736,818
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
multiple interactions |
EXP |
Phenylephrine promotes the reaction [EGR1 protein binds to FGF2 promoter] |
CTD |
PMID:10779383 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fhl1 |
four and a half LIM domains 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of FHL1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr X:134,555,399...134,614,930
Ensembl chr X:134,555,479...134,614,928
|
|
G |
Fhl2 |
four and a half LIM domains 2 |
decreases response to substance |
EXP |
FHL2 gene mutant form results in decreased susceptibility to Phenylephrine |
CTD |
PMID:25358972 |
|
NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192
|
|
G |
Fis1 |
fission, mitochondrial 1 |
increases expression multiple interactions |
EXP |
Phenylephrine results in increased expression of FIS1 protein CAT protein inhibits the reaction [Phenylephrine results in increased expression of FIS1 protein]; N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Phenylephrine results in increased expression of FIS1 protein]; sanglifehrin A inhibits the reaction [Phenylephrine results in increased expression of FIS1 protein] |
CTD |
PMID:20886221 |
|
NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
multiple interactions increases expression |
EXP |
FLT1 protein promotes the reaction [Phenylephrine results in increased activity of PRKG1 protein] Phenylephrine results in increased expression of FLT1 protein |
CTD |
PMID:19542178 PMID:24903162 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Fn1 |
fibronectin 1 |
increases expression |
ISO |
Phenylephrine results in increased expression of FN1 protein |
CTD |
PMID:11821714 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression affects response to substance affects expression |
ISO EXP |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of FOS mRNA; U 0126 inhibits the reaction [Phenylephrine results in increased expression of FOS mRNA] Phenylephrine results in increased expression of FOS mRNA; Phenylephrine results in increased expression of FOS protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased expression of FOS mRNA]; 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of FOS mRNA]; [Phenylephrine co-treated with Adenosine Triphosphate] results in increased expression of FOS mRNA; AGT protein promotes the reaction [Phenylephrine results in increased expression of FOS mRNA]; N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of FOS mRNA]; N(6)-cyclopentyladenosine inhibits the reaction [Phenylephrine results in increased expression of FOS mRNA]; Phenylephrine promotes the reaction [ELK1 protein modified form binds to FOS promoter]; Phenylephrine promotes the reaction [JUN protein binds to FOS protein]; PRKCZ protein affects the reaction [Phenylephrine results in increased expression of FOS mRNA]; Troglitazone inhibits the reaction [Phenylephrine results in increased expression of FOS protein] Phenylephrine results in increased expression of FOS; Phenylephrine results in increased expression of FOS mRNA; Phenylephrine results in increased expression of FOS protein FOS protein affects the susceptibility to Phenylephrine Phenylephrine affects the expression of FOS protein |
CTD |
PMID:7844257 PMID:7900855 PMID:7905536 PMID:8750937 PMID:8809800 PMID:8949925 PMID:9412514 PMID:10422649 PMID:10710348 PMID:10861511 PMID:10900171 PMID:11854500 PMID:12717712 PMID:12729908 PMID:14764439 PMID:15059776 PMID:15452191 PMID:16690042 PMID:18158353 PMID:19225867 PMID:19463813 PMID:27094369 More...
|
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
increases activity increases expression |
EXP |
Phenylephrine results in increased activity of FOSB protein Phenylephrine results in increased expression of FOSB |
CTD |
PMID:7905536 PMID:15949472 |
|
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
|
|
G |
Foxo1 |
forkhead box O1 |
multiple interactions |
EXP |
Phenylephrine promotes the reaction [FOXO1 protein results in increased expression of TNF mRNA]; Phenylephrine results in increased expression of and results in decreased phosphorylation of and affects the localization of FOXO1 protein |
CTD |
PMID:16020479 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Fstl3 |
follistatin like 3 |
affects expression |
EXP |
Phenylephrine affects the expression of FSTL3 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 7:9,923,574...9,929,223
Ensembl chr 7:9,923,576...9,939,639
|
|
G |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
increases expression |
EXP |
Phenylephrine results in increased expression of FXYD5 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:86,267,937...86,277,329
Ensembl chr 1:86,267,406...86,277,519
|
|
G |
Galnt13 |
polypeptide N-acetylgalactosaminyltransferase 13 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of GALNT13 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 3:38,903,695...39,560,683
Ensembl chr 3:38,974,490...39,558,803
|
|
G |
Gamt |
guanidinoacetate N-methyltransferase |
decreases expression |
EXP |
Phenylephrine results in decreased expression of GAMT mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 7:9,448,590...9,451,413
Ensembl chr 7:9,448,628...9,451,778
|
|
G |
Gata4 |
GATA binding protein 4 |
multiple interactions affects response to substance increases acetylation increases expression increases activity |
ISO EXP |
EP300 protein promotes the reaction [[Phenylephrine results in increased activity of GATA4 protein] which results in increased expression of EDN1 mRNA] [Phenylephrine co-treated with Isoproterenol] results in increased expression of GATA4 mRNA GATA4 protein affects the susceptibility to Phenylephrine 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased activity of GATA4 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased phosphorylation of GATA4 protein]; latrunculin B inhibits the reaction [Phenylephrine results in increased activity of GATA4 protein]; MAPK1 protein affects the reaction [Phenylephrine results in increased phosphorylation of GATA4 protein]; MAPK3 protein affects the reaction [Phenylephrine results in increased phosphorylation of GATA4 protein]; Phenylephrine promotes the reaction [GATA4 protein binds to EDN1 promoter]; Phenylephrine promotes the reaction [GATA4 protein binds to EP300 protein]; Phenylephrine results in increased phosphorylation of and results in increased activity of GATA4 protein; Y 27632 inhibits the reaction [Phenylephrine results in increased activity of GATA4 protein]; ZFPM2 protein inhibits the reaction [Phenylephrine promotes the reaction [GATA4 protein binds to EP300 protein]]; ZFPM2 protein inhibits the reaction [Phenylephrine results in increased activity of GATA4 protein] Phenylephrine results in increased acetylation of GATA4 protein Phenylephrine results in increased expression of GATA4 protein |
CTD |
PMID:10710348 PMID:10788492 PMID:11739382 PMID:12724418 PMID:15220332 PMID:18252717 PMID:19966502 PMID:20067472 More...
|
|
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
|
|
G |
Gdf15 |
growth differentiation factor 15 |
affects expression |
ISO |
Phenylephrine affects the expression of GDF15 mRNA |
CTD |
PMID:19505289 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
multiple interactions |
ISO |
Phenylephrine promotes the reaction [Ethylene Dibromide results in increased activity of GGT1 protein] |
CTD |
PMID:12628311 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions affects response to substance increases expression |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased expression of GJA1 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased expression of GJA1 protein]; bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased expression of GJA1 mRNA]; bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased expression of GJA1 protein]; SB 203580 inhibits the reaction [Phenylephrine results in increased expression of GJA1 mRNA]; SB 203580 inhibits the reaction [Phenylephrine results in increased expression of GJA1 protein] GJA1 protein affects the susceptibility to Phenylephrine Phenylephrine results in increased expression of GJA1 mRNA; Phenylephrine results in increased expression of GJA1 protein |
CTD |
PMID:16352648 PMID:18445782 PMID:18593691 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gja5 |
gap junction protein, alpha 5 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of GJA5 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 2:184,602,407...184,621,952
Ensembl chr 2:184,564,475...184,621,952
|
|
G |
Gla |
galactosidase, alpha |
affects response to substance |
ISO |
GLA protein affects the susceptibility to Phenylephrine |
CTD |
PMID:18565198 |
|
NCBI chr X:97,769,227...97,780,646
Ensembl chr X:97,768,996...97,780,664
|
|
G |
Glrx3 |
glutaredoxin 3 |
affects response to substance multiple interactions increases expression |
EXP |
GLRX3 protein affects the susceptibility to Phenylephrine GLRX3 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA protein]; GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK8 protein]; GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of PRKCA protein]; GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of PRKCE protein]; GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of PRKCZ protein] Phenylephrine results in increased expression of GLRX3 mRNA |
CTD |
PMID:16809552 |
|
NCBI chr 1:192,241,707...192,272,012
Ensembl chr 1:192,241,701...192,272,010
|
|
G |
Gmfg |
glia maturation factor, gamma |
increases expression |
EXP |
Phenylephrine results in increased expression of GMFG mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:83,728,797...83,739,189
Ensembl chr 1:83,728,776...83,739,183
|
|
G |
Gnaq |
G protein subunit alpha q |
multiple interactions |
EXP |
RTKI cpd inhibits the reaction [GNAQ protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]]; Uridine Triphosphate inhibits the reaction [GNAQ protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]] |
CTD |
PMID:14676212 |
|
NCBI chr 1:213,425,631...213,671,947
Ensembl chr 1:213,424,465...213,667,672
|
|
G |
Gnas |
GNAS complex locus |
affects response to substance |
EXP |
GNAS protein affects the susceptibility to Phenylephrine |
CTD |
PMID:10696522 |
|
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
|
|
G |
Gnrh1 |
gonadotropin releasing hormone 1 |
multiple interactions decreases secretion increases secretion |
EXP |
alfuzosin inhibits the reaction [Phenylephrine results in decreased secretion of GNRH1 protein]; alfuzosin inhibits the reaction [Phenylephrine results in increased secretion of GNRH1 protein]; Testosterone affects the reaction [Phenylephrine affects the secretion of GNRH1 protein] |
CTD |
PMID:1975657 |
|
NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581 Ensembl chr15:41,972,905...41,973,581
|
|
G |
Gpm6a |
glycoprotein m6a |
decreases expression |
EXP |
Phenylephrine results in decreased expression of GPM6A mRNA |
CTD |
PMID:18158353 |
|
NCBI chr16:36,641,282...36,973,377
Ensembl chr16:36,641,284...36,973,475
|
|
G |
Grk2 |
G protein-coupled receptor kinase 2 |
multiple interactions increases expression |
ISO EXP |
[Phenylephrine co-treated with ADRA1B protein] results in increased expression of GRK2 protein GRK2 protein affects the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; GRK2 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; GRK2 protein affects the reaction [Phenylephrine results in increased expression of NPPB mRNA]; GRK2 protein affects the reaction [Phenylephrine results in increased phosphorylation of AKT1 protein]; GRK2 protein affects the reaction [Phenylephrine results in increased phosphorylation of GSK3B protein] Phenylephrine results in increased expression of GRK2 protein |
CTD |
PMID:11499749 PMID:28759639 |
|
NCBI chr 1:201,580,823...201,601,580
Ensembl chr 1:201,581,480...201,601,582
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions increases phosphorylation |
EXP |
GRK2 protein affects the reaction [Phenylephrine results in increased phosphorylation of GSK3B protein]; SGK1 protein promotes the reaction [Phenylephrine results in increased phosphorylation of GSK3B protein] |
CTD |
PMID:15795328 PMID:28759639 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of GSTK1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of GSTM3 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
|
|
G |
Gys2 |
glycogen synthase 2 |
decreases activity |
EXP |
Phenylephrine results in decreased activity of GYS2 protein |
CTD |
PMID:747652 |
|
NCBI chr 4:175,365,054...175,406,228
Ensembl chr 4:175,365,054...175,406,228
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
decreases expression |
EXP |
Phenylephrine results in decreased expression of HAMP mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
increases expression |
EXP |
Phenylephrine results in increased expression of DTR mRNA |
CTD |
PMID:18158353 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Hdac5 |
histone deacetylase 5 |
multiple interactions |
ISO |
[Phenylephrine results in increased activity of PRKD1 protein] which affects the localization of HDAC5 protein |
CTD |
PMID:19124542 |
|
NCBI chr10:87,152,978...87,187,921
Ensembl chr10:87,152,978...87,188,235
|
|
G |
Hdgfl2 |
HDGF like 2 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of HDGFL2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 9:909,581...929,195
Ensembl chr 9:909,614...929,186
|
|
G |
Herc3 |
HECT and RLD domain containing E3 ubiquitin protein ligase 3 |
increases expression |
EXP |
Phenylephrine results in increased expression of HERC3 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 4:87,952,202...88,042,492
Ensembl chr 4:87,952,274...88,042,488
|
|
G |
Hexim1 |
HEXIM P-TEFb complex subunit 1 |
multiple interactions |
EXP |
Phenylephrine inhibits the reaction [HEXIM1 protein binds to CCNT1 protein] |
CTD |
PMID:17459355 |
|
NCBI chr10:88,062,808...88,064,920
Ensembl chr10:88,062,803...88,066,189
|
|
G |
Hey2 |
hes-related family bHLH transcription factor with YRPW motif 2 |
multiple interactions decreases response to substance decreases expression |
ISO |
HEY2 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; HEY2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; HEY2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA] HEY2 protein results in decreased susceptibility to Phenylephrine Phenylephrine results in decreased expression of HEY2 mRNA |
CTD |
PMID:16603706 PMID:20001863 |
|
NCBI chr 1:26,822,131...26,832,218
Ensembl chr 1:26,822,131...26,832,218
|
|
G |
Higd1a |
HIG1 hypoxia inducible domain family, member 1A |
increases expression |
EXP |
Phenylephrine results in increased expression of HIGD1A mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 8:121,514,152...121,523,382
Ensembl chr 8:121,514,156...121,523,443
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of HMGCS1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Homer1 |
homer scaffold protein 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of HOMER1 mRNA alternative form |
CTD |
PMID:16786172 |
|
NCBI chr 2:24,542,777...24,645,715
Ensembl chr 2:24,543,093...24,644,785
|
|
G |
Hspb3 |
heat shock protein family B (small) member 3 |
increases expression |
EXP |
Phenylephrine results in increased expression of HSPB3 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 2:45,295,285...45,295,999
Ensembl chr 2:45,295,053...45,296,145
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
increases expression increases expression |
EXP |
Phenylephrine results in increased expression of ID1 mRNA phenylephrine increases expression of mRNA in neonatal rat cardiomyocytes |
CTD RGD |
PMID:18158353 PMID:26873969 |
RGD:11526363 |
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Id4 |
inhibitor of DNA binding 4 |
increases expression |
EXP |
Phenylephrine results in increased expression of ID4 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr17:16,389,387...16,391,956
Ensembl chr17:16,389,387...16,392,470
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of IDI1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Ier3 |
immediate early response 3 |
decreases response to substance affects localization |
ISO |
IER3 protein results in decreased susceptibility to Phenylephrine Phenylephrine affects the localization of IER3 protein |
CTD |
PMID:11934837 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Igf1 |
insulin-like growth factor 1 |
affects response to substance |
EXP |
IGF1 protein affects the susceptibility to Phenylephrine |
CTD |
PMID:11159833 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
affects response to substance |
EXP |
IGFBP4 protein affects the susceptibility to Phenylephrine |
CTD |
PMID:11159833 |
|
NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225
|
|
G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of IGFBP5 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
increases activity multiple interactions |
EXP |
Phenylephrine results in increased activity of IKBKB protein IKBKB protein promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] |
CTD |
PMID:11381115 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions affects response to substance decreases response to substance |
EXP |
Halothane affects the reaction [IL1B protein affects the susceptibility to Phenylephrine] IL1B protein results in decreased susceptibility to Phenylephrine |
CTD |
PMID:11506125 PMID:13679239 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
increases expression decreases expression multiple interactions |
EXP |
Phenylephrine results in increased expression of IL6 mRNA Phenylephrine results in decreased expression of IL6 mRNA [resveratrol co-treated with Phenylephrine] results in increased expression of IL6 mRNA |
CTD |
PMID:11406463 PMID:12423672 PMID:22748497 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ilk |
integrin-linked kinase |
multiple interactions affects localization |
ISO EXP |
Phenylephrine affects the reaction [ANGPT1 protein results in increased expression of ILK protein] ILK protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA] Phenylephrine affects the localization of ILK protein |
CTD |
PMID:16170337 PMID:18502941 |
|
NCBI chr 1:160,088,839...160,095,140
Ensembl chr 1:160,088,897...160,095,140
|
|
G |
Inha |
inhibin subunit alpha |
increases expression |
EXP |
Phenylephrine results in increased expression of INHA mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:76,993,589...76,997,248
|
|
G |
Irf7 |
interferon regulatory factor 7 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of IRF7 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
|
|
G |
Isg15 |
ISG15 ubiquitin-like modifier |
decreases expression |
EXP |
Phenylephrine results in decreased expression of ISG15 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
|
|
G |
Itga9 |
integrin subunit alpha 9 |
increases expression |
EXP |
Phenylephrine results in increased expression of ITGA9 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 8:118,307,424...118,615,527
Ensembl chr 8:118,307,381...118,613,754
|
|
G |
Itgb3bp |
integrin subunit beta 3 binding protein |
increases expression |
EXP |
Phenylephrine results in increased expression of ITGB3BP mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:114,460,217...114,525,538
Ensembl chr 5:114,460,221...114,525,704
|
|
G |
Itgb8 |
integrin subunit beta 8 |
increases expression |
EXP |
Phenylephrine results in increased expression of ITGB8 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 6:140,125,002...140,208,261
Ensembl chr 6:140,127,203...140,208,476
|
|
G |
Itpr2 |
inositol 1,4,5-trisphosphate receptor, type 2 |
increases activity multiple interactions |
ISO |
Phenylephrine results in increased activity of ITPR2 protein [Phenylephrine results in increased activity of ITPR2 protein] which results in increased expression of ACTA1 mRNA; [Phenylephrine results in increased activity of ITPR2 protein] which results in increased expression of NPPA mRNA |
CTD |
PMID:15201137 |
|
NCBI chr 4:179,028,594...179,434,657
Ensembl chr 4:179,027,281...179,404,164
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression affects response to substance increases activity increases phosphorylation |
ISO EXP |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of JUN mRNA; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of JUN mRNA] Phenylephrine results in increased expression of JUN mRNA 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased expression of JUN mRNA]; CEP-11004 inhibits the reaction [Phenylephrine results in increased phosphorylation of JUN protein]; JUN gene mutant form inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; JUN gene mutant form inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA]; MAPK1 protein promotes the reaction [Phenylephrine results in increased expression of JUN mRNA]; MAPK3 protein promotes the reaction [Phenylephrine results in increased expression of JUN mRNA]; Phenylephrine inhibits the reaction [MAPK7 protein results in increased expression of JUN protein]; Phenylephrine promotes the reaction [JUN protein binds to FOS protein]; pyrazolanthrone inhibits the reaction [Phenylephrine results in increased expression of JUN mRNA]; Ro 31-8220 inhibits the reaction [Phenylephrine results in increased expression of JUN mRNA]; RPS6KA5 protein promotes the reaction [Phenylephrine results in increased expression of JUN mRNA]; SB 203580 inhibits the reaction [Phenylephrine results in increased expression of JUN mRNA] JUN protein affects the susceptibility to Phenylephrine Phenylephrine results in increased activity of JUN protein Phenylephrine results in increased expression of JUN; Phenylephrine results in increased expression of JUN mRNA; Phenylephrine results in increased expression of JUN protein |
CTD |
PMID:7905536 PMID:10710348 PMID:11799083 PMID:12169099 PMID:12574153 PMID:14764439 PMID:15949472 PMID:16690042 PMID:19002563 PMID:19225867 PMID:19443575 PMID:20067472 More...
|
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
increases expression increases activity |
EXP |
Phenylephrine results in increased expression of JUNB Phenylephrine results in increased activity of JUNB protein |
CTD |
PMID:7905536 PMID:15949472 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Jund |
JunD proto-oncogene, AP-1 transcription factor subunit |
multiple interactions decreases expression |
ISO |
JUND protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] Phenylephrine results in decreased expression of JUND mRNA |
CTD |
PMID:16690042 |
|
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
|
|
G |
Kcnd2 |
potassium voltage-gated channel subfamily D member 2 |
multiple interactions decreases response to substance decreases expression |
EXP |
CABIN1 protein promotes the reaction [Phenylephrine results in decreased expression of KCND2 mRNA]; CABIN1 protein promotes the reaction [Phenylephrine results in decreased expression of KCND2 protein]; KCND2 protein inhibits the reaction [Phenylephrine results in increased activity of NFATC1 protein]; KCND2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] KCND2 protein results in decreased susceptibility to Phenylephrine Phenylephrine results in decreased expression of KCND2 mRNA; Phenylephrine results in decreased expression of KCND2 protein |
CTD |
PMID:12403671 PMID:16385079 PMID:17060317 |
|
NCBI chr 4:49,775,812...50,277,746
Ensembl chr 4:49,776,246...50,277,728
|
|
G |
Kcnd3 |
potassium voltage-gated channel subfamily D member 3 |
multiple interactions decreases expression |
ISO EXP |
[KCND3 protein co-treated with ADRA1A protein] affects the susceptibility to Phenylephrine; chelerythrine inhibits the reaction [Phenylephrine results in decreased activity of KCND3 protein alternative form]; Phenylephrine results in decreased activity of [KCND3 protein alternative form co-treated with ADRA1A protein] Phenylephrine results in decreased expression of KCND3 mRNA; Phenylephrine results in decreased expression of KCND3 protein |
CTD |
PMID:11249870 PMID:11709419 PMID:16385079 PMID:17060317 |
|
NCBI chr 2:192,937,950...193,155,345
Ensembl chr 2:192,937,950...193,155,345
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
multiple interactions |
ISO |
Phenylephrine affects the reaction [KCNH2 protein results in increased transport of Potassium] |
CTD |
PMID:19419905 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Kcnip2 |
potassium voltage-gated channel interacting protein 2 |
multiple interactions decreases expression |
EXP |
MAPK8 protein affects the reaction [Phenylephrine results in decreased expression of KCNIP2 mRNA] Phenylephrine results in decreased expression of KCNIP2 mRNA; Phenylephrine results in decreased expression of KCNIP2 mRNA alternative form; Phenylephrine results in decreased expression of KCNIP2 protein |
CTD |
PMID:16385079 PMID:17060317 PMID:18158353 |
|
NCBI chr 1:244,641,147...244,664,939
Ensembl chr 1:244,641,150...244,664,874
|
|
G |
Kdelr3 |
KDEL endoplasmic reticulum protein retention receptor 3 |
increases expression |
EXP |
Phenylephrine results in increased expression of KDELR3 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 7:111,079,236...111,089,463
Ensembl chr 7:111,079,218...111,101,600
|
|
G |
Kdr |
kinase insert domain receptor |
decreases expression increases expression multiple interactions |
EXP |
Phenylephrine results in decreased expression of KDR mRNA Phenylephrine results in increased expression of KDR protein Copper inhibits the reaction [Phenylephrine results in increased expression of KDR protein] |
CTD |
PMID:18158353 PMID:24903162 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Kif5b |
kinesin family member 5B |
decreases expression |
EXP |
Phenylephrine results in decreased expression of KIF5B mRNA |
CTD |
PMID:18158353 |
|
NCBI chr17:51,489,904...51,527,508
Ensembl chr17:51,489,944...51,527,508
|
|
G |
Klf4 |
KLF transcription factor 4 |
multiple interactions decreases expression |
EXP |
Phenylephrine inhibits the reaction [KLF4 protein binds to NPPA promoter]; SK-7041 inhibits the reaction [Phenylephrine inhibits the reaction [KLF4 protein binds to NPPA promoter]] Phenylephrine results in decreased expression of KLF4 mRNA; Phenylephrine results in decreased expression of KLF4 protein |
CTD |
PMID:19729022 |
|
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
|
|
G |
Klhl24 |
kelch-like family member 24 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of KLHL24 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr11:80,843,621...80,877,649
Ensembl chr11:80,846,755...80,877,636
|
|
G |
Kmt2e |
lysine methyltransferase 2E |
decreases expression |
EXP |
Phenylephrine results in decreased expression of KMT2E mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 4:11,658,218...11,727,373
Ensembl chr 4:11,658,979...11,727,373
|
|
G |
Lamc1 |
laminin subunit gamma 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of LAMC1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr13:65,374,372...65,501,492
Ensembl chr13:65,374,372...65,501,492
|
|
G |
Lamc2 |
laminin subunit gamma 2 |
increases expression |
EXP |
Phenylephrine results in increased expression of LAMC2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
|
|
G |
Ldlr |
low density lipoprotein receptor |
increases expression |
EXP |
Phenylephrine results in increased expression of LDLR mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lgals3bp |
galectin 3 binding protein |
decreases expression |
EXP |
Phenylephrine results in decreased expression of LGALS3BP mRNA |
CTD |
PMID:18158353 |
|
NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256
|
|
G |
Lims1 |
LIM zinc finger domain containing 1 |
affects localization |
EXP |
Phenylephrine affects the localization of LIMS1 protein |
CTD |
PMID:16170337 |
|
NCBI chr20:26,309,833...26,418,511
Ensembl chr20:26,309,895...26,418,500
|
|
G |
Lmcd1 |
LIM and cysteine-rich domains 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of LMCD1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 4:145,393,153...145,452,049
Ensembl chr 4:145,393,145...145,452,046
|
|
G |
Lpl |
lipoprotein lipase |
affects response to substance |
ISO |
LPL protein affects the susceptibility to Phenylephrine |
CTD |
PMID:11786490 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Lrrc27 |
leucine rich repeat containing 27 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of LRRC27 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:194,004,967...194,035,087
Ensembl chr 1:194,005,182...194,035,084
|
|
G |
Lyl1 |
LYL1, basic helix-loop-helix family member |
increases expression |
EXP |
Phenylephrine results in increased expression of LYL1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr19:23,452,140...23,455,007
Ensembl chr19:23,452,140...23,455,007
|
|
G |
Mafk |
MAF bZIP transcription factor K |
increases expression |
EXP |
Phenylephrine results in increased expression of MAFK mRNA |
CTD |
PMID:18158353 |
|
NCBI chr12:14,834,628...14,856,414
Ensembl chr12:14,833,984...14,837,048 Ensembl chr12:14,833,984...14,837,048
|
|
G |
Man1a1 |
mannosidase, alpha, class 1A, member 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of MAN1A mRNA |
CTD |
PMID:18158353 |
|
NCBI chr20:33,202,509...33,385,747
Ensembl chr20:33,202,517...33,385,824
|
|
G |
Maoa |
monoamine oxidase A |
multiple interactions |
ISO |
[MAOB protein co-treated with MAOA protein] affects the susceptibility to Phenylephrine |
CTD |
PMID:11834493 |
|
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
|
|
G |
Maob |
monoamine oxidase B |
multiple interactions |
ISO |
[MAOB protein co-treated with MAOA protein] affects the susceptibility to Phenylephrine |
CTD |
PMID:11834493 |
|
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
multiple interactions |
EXP |
MAP2K1 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; MAP2K1 protein affects the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; MAP2K1 protein affects the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:10888249 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
multiple interactions |
EXP |
MEKK1 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA] |
CTD |
PMID:10727428 |
|
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
multiple interactions increases activity |
EXP |
CAMK2D protein promotes the reaction [Phenylephrine results in increased activity of MAP3K5 protein]; KN 93 inhibits the reaction [Phenylephrine results in increased activity of MAP3K5 protein] |
CTD |
PMID:15629441 |
|
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
|
|
G |
Map3k7 |
mitogen activated protein kinase kinase kinase 7 |
increases phosphorylation multiple interactions |
EXP |
phenylephrin increases phosphorylation of Map3k7 protein in neonatal cardiomyocytes Phenylephrine increases phosphorylation of Map3k7 protein in neonatal cardiomyocytes Phenylephrine promotes the reaction [Map3k7 protein binds to Ripk2 protein] Phenylephrine promotes the reaction [Map3k7 protein binds to Tab1 protein in neonatal cardiomyocytes] |
RGD |
PMID:32971071 PMID:35490166 PMID:34733837 PMID:35352799 |
RGD:155791643, RGD:155791668, RGD:155791674, RGD:155804287 |
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases activity affects phosphorylation increases expression increases phosphorylation |
ISO EXP |
[Phenylephrine co-treated with ADRA1A protein] results in increased phosphorylation of MAPK1 protein; [Phenylephrine co-treated with ADRA1B protein] results in increased phosphorylation of MAPK1 protein; [Phenylephrine co-treated with ADRA1D protein] results in increased phosphorylation of MAPK1 protein; [Timolol co-treated with Phenylephrine] results in increased phosphorylation of and results in increased activity of MAPK1 protein; carvedilol inhibits the reaction [[Phenylephrine co-treated with ADRA1A protein] results in increased phosphorylation of MAPK1 protein]; carvedilol inhibits the reaction [[Phenylephrine co-treated with ADRA1B protein] results in increased phosphorylation of MAPK1 protein]; carvedilol inhibits the reaction [[Phenylephrine co-treated with ADRA1D protein] results in increased phosphorylation of MAPK1 protein]; CAV3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; Phentolamine inhibits the reaction [[Phenylephrine co-treated with ADRA1A protein] results in increased phosphorylation of MAPK1 protein]; Phentolamine inhibits the reaction [[Phenylephrine co-treated with ADRA1B protein] results in increased phosphorylation of MAPK1 protein]; Phentolamine inhibits the reaction [[Phenylephrine co-treated with ADRA1D protein] results in increased phosphorylation of MAPK1 protein]; Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein; RGS3 protein affects the reaction [[Timolol co-treated with Phenylephrine] results in increased phosphorylation of and results in increased activity of MAPK1 protein]; RGS4 protein affects the reaction [[Timolol co-treated with Phenylephrine] results in increased phosphorylation of and results in increased activity of MAPK1 protein] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; Atorvastatin inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; NPY5R protein affects the reaction [NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]]; Pertussis Toxin inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein; Prazosin inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; RTKI cpd inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]]; Tetradecanoylphorbol Acetate inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] Phenylephrine results in increased activity of MAPK1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Phenylephrine results in increased activity of MAPK1 protein]; [EGF protein binds to EGFR protein] promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; [Phenylephrine results in increased phosphorylation of MAPK1 protein] which affects the expression of TGFB1I1 protein; ADAM17 protein affects the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased activity of MAPK1 protein]; bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; bisindolylmaleimide inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; BMY 7378 inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; calphostin C inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; CAT protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Cyclosporine inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Docosahexaenoic Acids inhibits the reaction [Phenylephrine results in increased phosphorylation of and affects the localization of MAPK1 protein]; DUSP6 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; latrunculin B inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Lovastatin inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; MAP2K1 protein affects the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; MAPK1 protein affects the reaction [Phenylephrine results in increased expression of ELK1 mRNA]; MAPK1 protein affects the reaction [Phenylephrine results in increased phosphorylation of GATA4 protein]; MAPK1 protein promotes the reaction [Phenylephrine results in increased expression of EP300 mRNA]; MAPK1 protein promotes the reaction [Phenylephrine results in increased expression of JUN mRNA]; N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Phenylephrine results in increased phosphorylation of and affects the localization of MAPK1 protein; Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein; Prazosin inhibits the reaction [Phenylephrine results in increased activity of MAPK1 protein]; Prazosin inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; RGS2 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Ro 31-8220 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; rottlerin inhibits the reaction [Phenylephrine results in increased activity of MAPK1 protein]; rottlerin promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; RTKI cpd inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Ruthenium Red inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; SLC9A1 protein promotes the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; U 0126 inhibits the reaction [Phenylephrine results in increased activity of MAPK1 protein]; Y 27632 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] Phenylephrine affects the phosphorylation of MAPK1 protein Phenylephrine results in increased expression of MAPK1 protein modified form |
CTD |
PMID:10422649 PMID:10660688 PMID:10727428 PMID:10788492 PMID:10888249 PMID:10900171 PMID:11195782 PMID:11693273 PMID:11705990 PMID:11739382 PMID:11804996 PMID:11854500 PMID:12094073 PMID:12213976 PMID:12513686 PMID:12720544 PMID:12729908 PMID:12847114 PMID:14676212 PMID:14975926 PMID:15007106 PMID:15258898 PMID:15306222 PMID:15452191 PMID:15757502 PMID:16513848 PMID:16517124 PMID:16760267 PMID:16809552 PMID:16877402 PMID:17306214 PMID:18084315 PMID:18360054 PMID:18445782 PMID:18977218 PMID:19002563 PMID:19002953 PMID:19540241 More...
|
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk10 |
mitogen activated protein kinase 10 |
multiple interactions |
ISO |
MAPK10 protein affects the reaction [MAPK9 protein affects the susceptibility to Phenylephrine] |
CTD |
PMID:16949803 |
|
NCBI chr14:6,497,662...6,790,109
Ensembl chr14:6,497,707...6,786,201
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
increases phosphorylation |
EXP |
Phenylephrine results in increased phosphorylation of MAPK14 protein |
CTD |
PMID:15757502 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases activity affects phosphorylation increases expression increases phosphorylation |
ISO EXP |
[Phenylephrine co-treated with ADRA1A protein] results in increased phosphorylation of MAPK3 protein; [Phenylephrine co-treated with ADRA1B protein] results in increased phosphorylation of MAPK3 protein; [Phenylephrine co-treated with ADRA1D protein] results in increased phosphorylation of MAPK3 protein; [Timolol co-treated with Phenylephrine] results in increased phosphorylation of and results in increased activity of MAPK3 protein; Carvedilol inhibits the reaction [[Phenylephrine co-treated with ADRA1A protein] results in increased phosphorylation of MAPK3 protein]; Carvedilol inhibits the reaction [[Phenylephrine co-treated with ADRA1B protein] results in increased phosphorylation of MAPK3 protein]; Carvedilol inhibits the reaction [[Phenylephrine co-treated with ADRA1D protein] results in increased phosphorylation of MAPK3 protein]; CAV3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; Phentolamine inhibits the reaction [[Phenylephrine co-treated with ADRA1A protein] results in increased phosphorylation of MAPK3 protein]; Phentolamine inhibits the reaction [[Phenylephrine co-treated with ADRA1B protein] results in increased phosphorylation of MAPK3 protein]; Phentolamine inhibits the reaction [[Phenylephrine co-treated with ADRA1D protein] results in increased phosphorylation of MAPK3 protein]; Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein; RGS3 protein affects the reaction [[Timolol co-treated with Phenylephrine] results in increased phosphorylation of and results in increased activity of MAPK3 protein]; RGS4 protein affects the reaction [[Timolol co-treated with Phenylephrine] results in increased phosphorylation of and results in increased activity of MAPK3 protein] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; Atorvastatin inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; NPY5R protein affects the reaction [NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]]; Pertussis Toxin inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein; Prazosin inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; RTKI cpd inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]]; Tetradecanoylphorbol Acetate inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein] Phenylephrine results in increased activity of MAPK3 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Phenylephrine results in increased activity of MAPK3 protein]; [EGF protein binds to EGFR protein] promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; [Phenylephrine results in increased phosphorylation of MAPK3 protein] which affects the expression of TGFB1I1 protein; ADAM17 protein affects the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased activity of MAPK3 protein]; bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; bisindolylmaleimide inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; BMY 7378 inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; calphostin C inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; CAT protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Cyclosporine inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Docosahexaenoic Acids inhibits the reaction [Phenylephrine results in increased phosphorylation of and affects the localization of MAPK3 protein]; DUSP6 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; latrunculin B inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; MAP2K1 protein affects the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; MAPK3 protein affects the reaction [Phenylephrine results in increased expression of ELK1 mRNA]; MAPK3 protein affects the reaction [Phenylephrine results in increased phosphorylation of GATA4 protein]; MAPK3 protein promotes the reaction [Phenylephrine results in increased expression of JUN mRNA]; N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Phenylephrine results in increased phosphorylation of and affects the localization of MAPK3 protein; Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein; Prazosin inhibits the reaction [Phenylephrine results in increased activity of MAPK3 protein]; Prazosin inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; RGS2 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Ro 31-8220 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; rottlerin inhibits the reaction [Phenylephrine results in increased activity of MAPK3 protein]; rottlerin promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; RTKI cpd inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Ruthenium Red inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; SLC9A1 protein promotes the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; U 0126 inhibits the reaction [Phenylephrine results in increased activity of MAPK3 protein]; Y 27632 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein] Phenylephrine affects the phosphorylation of MAPK3 protein Phenylephrine results in increased expression of MAPK3 protein modified form |
CTD |
PMID:10422649 PMID:10660688 PMID:10727428 PMID:10788492 PMID:10888249 PMID:10900171 PMID:11195782 PMID:11693273 PMID:11705990 PMID:11739382 PMID:11804996 PMID:11854500 PMID:12094073 PMID:12213976 PMID:12513686 PMID:12720544 PMID:12729908 PMID:12847114 PMID:14676212 PMID:14975926 PMID:15007106 PMID:15258898 PMID:15306222 PMID:15452191 PMID:15757502 PMID:16513848 PMID:16517124 PMID:16760267 PMID:16809552 PMID:16877402 PMID:17306214 PMID:18084315 PMID:18360054 PMID:18445782 PMID:18977218 PMID:19002563 PMID:19002953 PMID:19540241 More...
|
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk7 |
mitogen-activated protein kinase 7 |
multiple interactions |
EXP |
Phenylephrine inhibits the reaction [MAPK7 protein results in increased expression of JUN protein] |
CTD |
PMID:12574153 |
|
NCBI chr10:46,170,264...46,176,262
Ensembl chr10:46,170,167...46,176,267
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions increases phosphorylation |
EXP |
GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK8 protein]; MAPK8 protein affects the reaction [Phenylephrine results in decreased expression of KCNIP2 mRNA]; Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK8 protein; RGS2 protein promotes the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK8 protein] Phenylephrine results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:10727428 PMID:16385079 PMID:16517124 PMID:16809552 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk8ip1 |
mitogen-activated protein kinase 8 interacting protein 1 |
affects response to substance multiple interactions |
EXP |
MAPK8IP1 protein affects the susceptibility to Phenylephrine MAPK8IP1 protein inhibits the reaction [Phenylephrine results in increased expression of ACTA1 mRNA]; MAPK8IP1 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; MAPK8IP1 protein inhibits the reaction [Phenylephrine results in increased expression of MYL2 mRNA]; MAPK8IP1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] |
CTD |
PMID:11513749 |
|
NCBI chr 3:78,355,051...78,372,946
Ensembl chr 3:78,355,048...78,372,884
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions affects response to substance increases phosphorylation |
ISO EXP |
MAPK10 protein affects the reaction [MAPK9 protein affects the susceptibility to Phenylephrine] Phenylephrine results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:10727428 PMID:16949803 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Masp1 |
MBL associated serine protease 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of MASP1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr11:77,334,794...77,405,271
Ensembl chr11:77,334,859...77,402,974
|
|
G |
Mef2c |
myocyte enhancer factor 2C |
multiple interactions increases activity increases expression |
ISO EXP |
Go 6976 inhibits the reaction [Phenylephrine results in increased activity of MEF2C protein] 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Phenylephrine results in increased expression of MEF2C mRNA]; KN 62 inhibits the reaction [Phenylephrine results in increased expression of MEF2C mRNA] |
CTD |
PMID:10737771 PMID:19124542 |
|
NCBI chr 2:13,973,299...14,136,065
Ensembl chr 2:13,993,438...14,132,880
|
|
G |
Mfap4 |
microfibril associated protein 4 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of MFAP4 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr10:46,167,158...46,170,176
Ensembl chr10:46,167,217...46,170,155
|
|
G |
Mfhas1 |
multifunctional ROCO family signaling regulator 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of MFHAS1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr16:56,545,462...56,633,649
Ensembl chr16:56,546,207...56,633,743
|
|
G |
Mfn2 |
mitofusin 2 |
decreases expression multiple interactions |
EXP |
Phenylephrine results in decreased expression of MFN2 mRNA; Phenylephrine results in decreased expression of MFN2 protein CAT protein inhibits the reaction [Phenylephrine results in decreased expression of MFN2 protein]; N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Phenylephrine results in decreased expression of MFN2 protein]; Ruthenium Red inhibits the reaction [Phenylephrine results in decreased expression of MFN2 protein] |
CTD |
PMID:17499311 PMID:20886221 |
|
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
|
|
G |
Mgll |
monoglyceride lipase |
decreases expression |
EXP |
Phenylephrine results in decreased expression of MGLL mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
|
|
G |
Mir21 |
microRNA 21 |
increases expression |
EXP |
Phenylephrine results in increased expression of MIR21 mRNA |
CTD |
PMID:17525252 |
|
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mlkl |
mixed lineage kinase domain like pseudokinase |
increases expression |
ISO |
Phenylephrine results in increased expression of MLKL protein |
CTD |
PMID:31605733 |
|
NCBI chr19:39,277,526...39,304,555
Ensembl chr19:39,276,785...39,304,502
|
|
G |
Mllt11 |
MLLT11, transcription factor 7 cofactor |
increases expression |
EXP |
Phenylephrine results in increased expression of MLLT11 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 2:182,795,790...182,804,960
Ensembl chr 2:182,795,790...182,797,199
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO EXP |
MMP2 protein affects the susceptibility to [Phenylephrine co-treated with Oxygen deficiency] [Phenylephrine results in increased expression of AGT protein] which results in increased activity of MMP2 protein; Losartan inhibits the reaction [[Phenylephrine results in increased expression of AGT protein] which results in increased activity of MMP2 protein]; MMP2 protein affects the susceptibility to [Phenylephrine co-treated with Oxygen deficiency] |
CTD |
PMID:16251426 PMID:16980344 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
increases expression |
ISO |
Phenylephrine results in increased expression of MMP9 mRNA |
CTD |
PMID:16574429 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mov10l1 |
Mov10 like RNA helicase 1 |
multiple interactions |
ISO EXP |
MOV10L1 protein promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] MOV10L1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; MOV10L1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA] |
CTD |
PMID:11854500 PMID:12754203 |
|
NCBI chr 7:120,070,171...120,135,406
Ensembl chr 7:120,070,135...120,134,765
|
|
G |
Msmo1 |
methylsterol monooxygenase 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of MSMO1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
|
|
G |
Msn |
moesin |
increases expression |
EXP |
Phenylephrine results in increased expression of MSN mRNA |
CTD |
PMID:18158353 |
|
NCBI chr X:60,996,043...61,064,011
Ensembl chr X:60,995,951...61,065,628
|
|
G |
Mthfd1l |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
increases expression |
EXP |
Phenylephrine results in increased expression of MTHFD1L mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:40,443,926...40,632,911
Ensembl chr 1:40,444,008...40,632,905
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions |
EXP |
[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of MTOR protein; Calcium affects the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of MTOR protein]; Ethanol inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of MTOR protein] |
CTD |
PMID:12935885 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mustn1 |
musculoskeletal, embryonic nuclear protein 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of MUSTN1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr16:6,072,908...6,075,161
Ensembl chr16:6,072,833...6,075,161
|
|
G |
Mybl1 |
MYB proto-oncogene like 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of MYBL1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:9,582,905...9,618,179
Ensembl chr 5:9,582,934...9,618,183
|
|
G |
Mybpc3 |
myosin binding protein C3 |
multiple interactions |
ISO |
MYBPC3 gene mutant form results in increased susceptibility to [Isoproterenol co-treated with Phenylephrine] MYBPC3 mutant form results in increased susceptibility to [Isoproterenol co-treated with Phenylephrine] |
CTD |
PMID:22076249 |
|
NCBI chr 3:77,095,165...77,113,406
Ensembl chr 3:77,095,252...77,113,405
|
|
G |
Myh14 |
myosin heavy chain 14 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of MYH14 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:95,096,266...95,158,861
Ensembl chr 1:95,096,266...95,158,836
|
|
G |
Myh6 |
myosin heavy chain 6 |
multiple interactions decreases expression |
EXP |
Prazosin inhibits the reaction [Phenylephrine results in decreased expression of MYH6 mRNA]; THRA protein affects the reaction [Phenylephrine results in decreased expression of MYH6 protein]; Triiodothyronine inhibits the reaction [Phenylephrine results in decreased expression of MYH6 mRNA] |
CTD |
PMID:11577024 PMID:15578571 PMID:15795322 PMID:17592507 |
|
NCBI chr15:28,418,120...28,442,316
Ensembl chr15:28,417,616...28,441,720
|
|
G |
Myh7 |
myosin heavy chain 7 |
multiple interactions increases expression |
ISO EXP |
CAV3 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 protein] [Phenylephrine co-treated with Isoproterenol] results in increased expression of MYH7 mRNA; ANGPT1 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; HEY2 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA] anacardic acid inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; Colforsin inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; EP300 protein affects the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; EP300 protein promotes the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; EYA2 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 protein]; GRK2 protein affects the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; HS 142-1 promotes the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; Isoproterenol inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; MAPK8IP1 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; Metoprolol promotes the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; N(6)-phenyl-cAMP analog inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide promotes the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; Prazosin inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; Propranolol promotes the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; S100A6 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; S100B protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; SIRT6 protein affects the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; SIRT6 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; SK-7041 inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; spiruchostatin A inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; THRB protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 protein]; trichostatin A inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; Triiodothyronine inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; Y 27632 inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; ZFPM2 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA] Phenylephrine results in increased expression of MYH7 mRNA; Phenylephrine results in increased expression of MYH7 protein |
CTD |
PMID:10642269 PMID:10710348 PMID:11249870 PMID:11513749 PMID:11577024 PMID:11739382 PMID:12435817 PMID:12847114 PMID:15220332 PMID:15578571 PMID:15593114 PMID:15652358 PMID:15795322 PMID:16603706 PMID:17327491 PMID:17592507 PMID:18252717 PMID:18487437 PMID:18502941 PMID:18851973 PMID:19729022 PMID:27094368 PMID:28759639 More...
|
|
NCBI chr15:28,446,550...28,469,888
Ensembl chr15:28,446,550...28,468,217
|
|
G |
Myl1 |
myosin, light chain 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of MYL1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 9:68,437,514...68,458,256
Ensembl chr 9:68,437,517...68,458,261
|
|
G |
Myl2 |
myosin light chain 2 |
multiple interactions increases expression increases phosphorylation |
EXP |
ADM protein inhibits the reaction [Phenylephrine results in increased expression of MYL2 mRNA]; BQ 788 inhibits the reaction [Phenylephrine results in increased expression of MYL2 mRNA]; cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [Phenylephrine results in increased expression of MYL2 mRNA]; MAPK8IP1 protein inhibits the reaction [Phenylephrine results in increased expression of MYL2 mRNA]; MYOCD protein promotes the reaction [Phenylephrine results in increased expression of MYL2 protein]; Uridine Triphosphate inhibits the reaction [MYL2 protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]] Phenylephrine results in increased phosphorylation of MYL2 protein |
CTD |
PMID:11470465 PMID:11513749 PMID:14676212 PMID:15007106 PMID:18202317 |
|
NCBI chr12:34,454,223...34,468,554
Ensembl chr12:34,454,218...34,468,983
|
|
G |
Myl7 |
myosin light chain 7 |
multiple interactions increases phosphorylation |
ISO |
ML 7 inhibits the reaction [Phenylephrine results in increased phosphorylation of MYL7 protein]; wortmannin inhibits the reaction [Phenylephrine results in increased phosphorylation of MYL7 protein]; Y 27632 inhibits the reaction [Phenylephrine results in increased phosphorylation of MYL7 protein] |
CTD |
PMID:15621049 |
|
NCBI chr14:80,780,684...80,783,259
Ensembl chr14:80,779,776...80,783,244
|
|
G |
Myl9 |
myosin light chain 9 |
increases phosphorylation |
EXP |
Phenylephrine results in increased phosphorylation of MYL9 protein |
CTD |
PMID:18835913 |
|
NCBI chr 3:145,281,943...145,288,333
Ensembl chr 3:145,281,937...145,288,333
|
|
G |
Mylk3 |
myosin light chain kinase 3 |
increases phosphorylation |
ISO |
Phenylephrine results in increased phosphorylation of MYLK3 protein |
CTD |
PMID:18202317 |
|
NCBI chr19:21,685,085...21,743,587
Ensembl chr19:21,691,929...21,742,954
|
|
G |
Myocd |
myocardin |
multiple interactions increases expression |
EXP |
MYOCD protein affects the reaction [Phenylephrine results in increased expression of ACTA2 mRNA]; MYOCD protein affects the reaction [Phenylephrine results in increased expression of NPPB mRNA]; MYOCD protein promotes the reaction [Phenylephrine results in increased expression of MYL2 protein]; MYOCD protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]; Phenylephrine promotes the reaction [MYOCD protein binds to NPPA promoter] Phenylephrine results in increased expression of MYOCD mRNA; Phenylephrine results in increased expression of MYOCD protein |
CTD |
PMID:14676212 PMID:16556869 |
|
NCBI chr10:49,833,219...49,928,806
Ensembl chr10:49,836,641...49,927,627
|
|
G |
Myoz2 |
myozenin 2 |
multiple interactions decreases response to substance |
ISO |
MYOZ2 protein inhibits the reaction [Phenylephrine results in increased expression of RCAN1 protein] MYOZ2 protein results in decreased susceptibility to Phenylephrine |
CTD |
PMID:18025526 |
|
NCBI chr 2:211,141,463...211,168,187
Ensembl chr 2:211,141,463...211,168,221
|
|
G |
Nab1 |
Ngfi-A binding protein 1 |
multiple interactions |
ISO |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of NAB1 mRNA |
CTD |
PMID:10710348 |
|
NCBI chr 9:49,053,579...49,093,078
Ensembl chr 9:49,053,758...49,092,098
|
|
G |
Nab2 |
Ngfi-A binding protein 2 |
multiple interactions |
ISO |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of NAB2 mRNA; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of NAB2 mRNA] |
CTD |
PMID:10710348 |
|
NCBI chr 7:63,497,589...63,504,105
Ensembl chr 7:63,497,589...63,503,989
|
|
G |
Ncald |
neurocalcin delta |
increases expression |
EXP |
Phenylephrine results in increased expression of NCALD mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 7:68,532,671...68,964,740
Ensembl chr 7:68,534,421...68,964,496
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
increases phosphorylation increases expression |
EXP ISO |
Phenylephrine results in increased phosphorylation of NCF1 protein Phenylephrine results in increased expression of NCF1 mRNA |
CTD |
PMID:14656924 PMID:15936005 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Nfatc1 |
nuclear factor of activated T-cells 1 |
multiple interactions affects localization |
EXP |
Cyclosporine inhibits the reaction [Phenylephrine results in increased localization of and results in increased activity of NFATC1 protein]; KCND2 protein inhibits the reaction [Phenylephrine results in increased activity of NFATC1 protein]; Phenylephrine results in increased localization of and results in increased activity of NFATC1 protein; sanggenone C inhibits the reaction [Phenylephrine affects the localization of NFATC1 protein] |
CTD |
PMID:12403671 PMID:19349967 PMID:28849031 |
|
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
|
|
G |
Nfatc3 |
nuclear factor of activated T-cells 3 |
increases localization multiple interactions |
ISO |
Phenylephrine results in increased localization of NFATC3 protein [NPPA protein results in increased activity of NPR1 protein] promotes the reaction [Phenylephrine results in increased localization of NFATC3 protein] |
CTD |
PMID:15939815 |
|
NCBI chr19:33,960,643...34,035,150
Ensembl chr19:33,960,852...34,035,150
|
|
G |
Nfatc4 |
nuclear factor of activated T-cells 4 |
multiple interactions increases localization affects localization |
ISO EXP |
Cyclosporine inhibits the reaction [Phenylephrine results in increased localization of NFATC4 protein]; Tacrolimus inhibits the reaction [Phenylephrine results in increased localization of NFATC4 protein] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine affects the localization of NFATC4 protein]; Cyclosporine inhibits the reaction [Phenylephrine results in increased localization of NFATC4 protein]; Tacrolimus inhibits the reaction [Phenylephrine results in increased localization of NFATC4 protein] |
CTD |
PMID:11044444 PMID:16055480 |
|
NCBI chr15:29,286,998...29,314,610
Ensembl chr15:29,305,535...29,314,610
|
|
G |
Nfil3 |
nuclear factor, interleukin 3 regulated |
multiple interactions |
ISO |
U 0126 inhibits the reaction [Phenylephrine results in increased expression of NFIL3 mRNA] |
CTD |
PMID:12729908 |
|
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions decreases expression increases degradation |
EXP |
4-trifluoromethylsalicylic acid inhibits the reaction [Phenylephrine results in decreased expression of NFKBIA protein]; KN 93 inhibits the reaction [Phenylephrine results in increased degradation of NFKBIA protein]; NFKBIA protein promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] |
CTD |
PMID:11381115 PMID:15629441 PMID:16421291 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nid2 |
nidogen 2 |
increases expression |
EXP |
Phenylephrine results in increased expression of NID2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr15:4,458,082...4,513,808
Ensembl chr15:4,458,084...4,513,843
|
|
G |
Nkx2-5 |
NK2 homeobox 5 |
multiple interactions |
ISO |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of NKX2-5 mRNA |
CTD |
PMID:10710348 |
|
NCBI chr10:16,340,428...16,347,004
Ensembl chr10:16,344,159...16,346,934
|
|
G |
Nodal |
nodal growth differentiation factor |
affects expression |
EXP |
Phenylephrine affects the expression of NODAL mRNA; Phenylephrine affects the expression of NODAL protein |
CTD |
PMID:11029149 |
|
NCBI chr20:29,368,436...29,376,837
Ensembl chr20:29,368,436...29,376,837
|
|
G |
Nol3 |
nucleolar protein 3 |
decreases phosphorylation |
EXP |
Phenylephrine results in decreased phosphorylation of NOL3 protein |
CTD |
PMID:18171680 |
|
NCBI chr19:33,154,061...33,158,250
Ensembl chr19:33,154,062...33,158,250
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions affects response to substance decreases response to substance increases activity |
ISO EXP |
NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Acetylcholine]; NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Adenosine Diphosphate]; NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Calcimycin]; NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Nitroprusside] NOS2 protein affects the susceptibility to Phenylephrine NOS2 protein results in decreased susceptibility to Phenylephrine Phenylephrine results in increased activity of NOS2 protein Prazosin inhibits the reaction [Phenylephrine results in increased expression of NOS2 mRNA]; Prazosin inhibits the reaction [Phenylephrine results in increased expression of NOS2 protein] |
CTD |
PMID:11498454 PMID:15753950 PMID:15902277 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
affects response to substance decreases response to substance increases expression multiple interactions |
ISO EXP |
NOS3 protein affects the susceptibility to Phenylephrine NOS3 protein results in decreased susceptibility to Phenylephrine Phenylephrine results in increased expression of NOS3 mRNA; Phenylephrine results in increased expression of NOS3 protein NOS3 protein results in increased susceptibility to [Acetylcholine co-treated with Phenylephrine] |
CTD |
PMID:10954898 PMID:11504159 PMID:15381055 PMID:15753950 PMID:17403420 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nppa |
natriuretic peptide A |
increases secretion multiple interactions increases expression decreases response to substance increases expression |
ISO EXP |
Phenylephrine results in increased secretion of NPPA protein [NPPA protein results in increased activity of NPR1 protein] promotes the reaction [Phenylephrine results in increased localization of NFATC3 protein]; [Phenylephrine co-treated with ADRA1B protein] results in increased expression of NPPA protein; [Phenylephrine co-treated with Isoproterenol] results in increased expression of NPPA mRNA; [Phenylephrine results in increased activity of ITPR2 protein] which results in increased expression of NPPA mRNA; ANGPT1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; DGKZ protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of NPPA mRNA]; HEY2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; JUND protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; MOV10L1 protein promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] Phenylephrine results in increased expression of NPPA mRNA; Phenylephrine results in increased expression of NPPA protein NPPA protein results in decreased susceptibility to Phenylephrine (+)-JQ1 compound inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; (+)-JQ1 compound inhibits the reaction [Phenylephrine results in increased expression of NPPA protein]; 1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]]; 1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [N(6)-cyclopentyladenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]]; 2,3-diethyl-4,5-dipropyl-6-phenylpyridine-3-thiocarboxylate-5-carboxylate inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]]; 2,3-diethyl-4,5-dipropyl-6-phenylpyridine-3-thiocarboxylate-5-carboxylate inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Phenylephrine results in increased expression of NPPA protein]; 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; 2-aminoethoxydiphenyl borate inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; 2-Chloroadenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; 4-trifluoromethylsalicylic acid inhibits the reaction [Phenylephrine results in increased expression of NPPA protein]; 8-(3-chlorostyryl)caffeine inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]]; 8-(4-sulfophenyl)theophylline inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]]; [8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; [9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; [GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; [Phenylephrine co-treated with Oxygen deficiency] results in increased expression of NPPA mRNA; [Phenylephrine results in increased activity of CREBBP protein] which results in increased expression of NPPA protein; [Phenylephrine results in increased activity of EP300 protein] which results in increased expression of NPPA protein; [pirinixic acid binds to PPARA protein] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; [S-Nitroso-N-Acetylpenicillamine co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; [SIRT6 protein co-treated with EP300 protein] affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; ADM protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; ADORA1 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; ADORA2A protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; ADORA3 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; Aldosterone promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA]; BQ 788 inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; CABIN1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; CABIN1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA protein]; Caffeine analog inhibits the reaction [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]]; CEP-11004 inhibits the reaction [Phenylephrine results in increased secretion of NPPA protein]; chelerythrine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; chelerythrine promotes the reaction [2-aminoethoxydiphenyl borate inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]]; Colforsin inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; Corticosterone promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA]; CREBBP protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; Docosahexaenoic Acids inhibits the reaction [Phenylephrine affects the expression of NPPA protein]; EP300 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; EYA2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA protein]; Fulvestrant inhibits the reaction [[Estradiol co-treated with Phenylephrine] results in increased expression of NPPA protein]; GLRX3 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA protein]; GRK2 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; HS 142-1 promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA]; HS 142-1 promotes the reaction [Phenylephrine results in increased secretion of NPPA protein]; IKBKB protein promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA]; ILK protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; Isoproterenol inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; JUN gene mutant form inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; KCND2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; kenpaullone promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA]; leptomycin B inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Phenylephrine results in increased expression of NPPA protein]; MAP2K1 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; MAPK8IP1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; MBF1 protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]; MEKK1 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; Metoprolol promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA]; MOV10L1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; MYOCD protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]; N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; N(6)-cyclopentyladenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; N(6)-phenyl-cAMP analog inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA]; N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; NFKBIA protein promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA]; Ouabain promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA]; paricalcitol inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; PDE5A protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; Phenylephrine inhibits the reaction [KLF4 protein binds to NPPA promoter]; Phenylephrine promotes the reaction [BRD4 protein binds to NPPA promoter]; Phenylephrine promotes the reaction [CTNNB1 protein binds to NPPA promoter]; Phenylephrine promotes the reaction [EP300 protein binds to NPPA promoter]; Phenylephrine promotes the reaction [MYOCD protein binds to NPPA promoter]; polydatin inhibits the reaction [Phenylephrine results in increased expression of NPPA protein]; Prazosin inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; Prazosin inhibits the reaction [Phenylephrine results in increased expression of NPPA protein]; PRKCZ protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; Propranolol promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA]; Resveratrol inhibits the reaction [Phenylephrine promotes the reaction [EP300 protein binds to NPPA promoter]]; Resveratrol inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; RGS2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; RHOA protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; RTKI cpd inhibits the reaction [GNAQ protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]]; Ruthenium Red inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; sanglifehrin A inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; SB 203580 inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; Sildenafil Citrate inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; SIRT6 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; SK-7041 inhibits the reaction [Phenylephrine inhibits the reaction [KLF4 protein binds to NPPA promoter]]; SK-7041 inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; Spironolactone inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; TGFB1I1 protein promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA]; TGFB1I1 protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]; trichostatin A inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; triflusal inhibits the reaction [Phenylephrine results in increased expression of NPPA protein]; U 0126 inhibits the reaction [Phenylephrine results in increased expression of NPPA protein]; Uridine Triphosphate inhibits the reaction [GNAQ protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]]; Uridine Triphosphate inhibits the reaction [MYL2 protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]]; Uridine Triphosphate inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; xestospongin C inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; Y 27632 inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; Y 27632 inhibits the reaction [Phenylephrine results in increased expression of NPPA protein]; ZFPM2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] phenylephrine increases expression of mRNA in neonatal rat cardiomyocytes |
CTD RGD |
PMID:2847676 PMID:8188982 PMID:10642269 PMID:10655507 PMID:10679475 PMID:10710348 PMID:10727428 PMID:10843871 PMID:10888249 PMID:11042672 PMID:11230109 PMID:11299230 PMID:11381115 PMID:11470465 PMID:11499749 PMID:11513749 PMID:11705990 PMID:11739382 PMID:11754973 PMID:11799083 PMID:11799084 PMID:11804996 PMID:11836006 PMID:11854500 PMID:12403671 PMID:12435817 PMID:12477714 PMID:12513686 PMID:12682052 PMID:12729799 PMID:12754203 PMID:14676212 PMID:14718400 PMID:15007106 PMID:15191894 PMID:15201137 PMID:15220332 PMID:15258898 PMID:15452191 PMID:15522277 PMID:15721863 PMID:15795322 PMID:15939815 PMID:16170337 PMID:16380548 PMID:16421291 PMID:16513848 PMID:16517124 PMID:16533503 PMID:16556869 PMID:16603706 PMID:16690042 PMID:16787574 PMID:16809552 PMID:17124262 PMID:17204550 PMID:17266992 PMID:17287366 PMID:17327491 PMID:17499311 PMID:17592507 PMID:18252717 PMID:18378355 PMID:18487437 PMID:18502941 PMID:18701451 PMID:18790048 PMID:18851973 PMID:19111554 PMID:19540241 PMID:19729022 PMID:19799869 PMID:19966059 PMID:19966502 PMID:20067472 PMID:20886221 PMID:21565836 PMID:23297412 PMID:23939492 PMID:25341891 PMID:25358972 PMID:25449040 PMID:27094368 PMID:27094369 PMID:28759639 PMID:28822817 PMID:26873969 More...
|
RGD:11526363 |
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nppb |
natriuretic peptide B |
multiple interactions increases expression increases secretion increases expression |
ISO EXP |
ANGPT1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA]; HEY2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA] Phenylephrine results in increased secretion of NPPB protein (+)-JQ1 compound inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA]; [GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA]; [pirinixic acid binds to PPARA protein] inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA]; [SIRT6 protein co-treated with EP300 protein] affects the reaction [Phenylephrine results in increased expression of NPPB mRNA]; CEP-11004 inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA]; CEP-11004 inhibits the reaction [Phenylephrine results in increased secretion of NPPB protein]; EP300 protein affects the reaction [Phenylephrine results in increased expression of NPPB mRNA]; GRK2 protein affects the reaction [Phenylephrine results in increased expression of NPPB mRNA]; HS 142-1 promotes the reaction [Phenylephrine results in increased secretion of NPPB protein]; JUN gene mutant form inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA]; MOV10L1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA]; MYOCD protein affects the reaction [Phenylephrine results in increased expression of NPPB mRNA]; PDE5A protein affects the reaction [Phenylephrine results in increased expression of NPPB mRNA]; PRKCZ protein affects the reaction [Phenylephrine results in increased expression of NPPB mRNA]; Sildenafil Citrate inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA]; SIRT6 protein inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA] Phenylephrine results in increased expression of NPPB mRNA; Phenylephrine results in increased expression of NPPB protein phenylephrine increases expression of mRNA in neonatal rat cardiomyocytes |
CTD RGD |
PMID:10642269 PMID:11754973 PMID:11799083 PMID:11804996 PMID:11854500 PMID:12435817 PMID:16556869 PMID:16603706 PMID:18502941 PMID:18701451 PMID:18790048 PMID:20067472 PMID:23939492 PMID:25358972 PMID:27094368 PMID:27094369 PMID:28759639 PMID:28822817 PMID:26873969 More...
|
RGD:11526363 |
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Nppc |
natriuretic peptide C |
affects response to substance multiple interactions |
EXP |
NPPC protein affects the susceptibility to Phenylephrine SMR3B protein promotes the reaction [NPPC protein affects the susceptibility to Phenylephrine] |
CTD |
PMID:17026587 |
|
NCBI chr 9:87,320,051...87,324,251
Ensembl chr 9:87,320,051...87,324,251
|
|
G |
Npr1 |
natriuretic peptide receptor 1 |
multiple interactions |
ISO |
[NPPA protein results in increased activity of NPR1 protein] promotes the reaction [Phenylephrine results in increased localization of NFATC3 protein] |
CTD |
PMID:15939815 |
|
NCBI chr 2:175,934,181...175,950,118
Ensembl chr 2:175,934,181...175,949,505
|
|
G |
Npy |
neuropeptide Y |
multiple interactions |
ISO |
[Phenylephrine co-treated with ADRA1B protein] results in decreased expression of NPY protein; NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]; NPY5R protein affects the reaction [NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]]; NPY5R protein affects the reaction [NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]]; Tetradecanoylphorbol Acetate inhibits the reaction [NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]]; Tetradecanoylphorbol Acetate inhibits the reaction [NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]] |
CTD |
PMID:10660688 PMID:11499749 |
|
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Npy5r |
neuropeptide Y receptor Y5 |
multiple interactions |
ISO |
NPY5R protein affects the reaction [NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]]; NPY5R protein affects the reaction [NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]] |
CTD |
PMID:10660688 |
|
NCBI chr16:23,055,427...23,063,384
Ensembl chr16:23,055,427...23,063,382
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
affects response to substance |
ISO |
NR1I2 protein affects the susceptibility to Phenylephrine |
CTD |
PMID:17159084 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of NR3C1 mRNA |
CTD |
PMID:16533503 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
multiple interactions increases expression |
EXP |
Phenylephrine promotes the reaction [NR3C2 protein binds to CREBBP protein]; Phenylephrine results in increased expression of and results in increased localization of NR3C2 protein; Spironolactone inhibits the reaction [Phenylephrine results in increased localization of NR3C2 protein] Phenylephrine results in increased expression of NR3C2 mRNA |
CTD |
PMID:16533503 PMID:19966502 |
|
NCBI chr19:30,715,634...31,059,885
Ensembl chr19:30,715,648...31,059,885
|
|
G |
Nr4a3 |
nuclear receptor subfamily 4, group A, member 3 |
increases expression |
EXP |
Phenylephrine results in increased expression of NR4A3 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:62,361,588...62,401,489
Ensembl chr 5:62,361,822...62,402,733
|
|
G |
Nrep |
neuronal regeneration related protein |
decreases expression |
EXP |
Phenylephrine results in decreased expression of NREP mRNA |
CTD |
PMID:18158353 |
|
NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591
|
|
G |
Nrg1 |
neuregulin 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of NRG1 mRNA; Phenylephrine results in decreased expression of NRG1 protein |
CTD |
PMID:16698793 |
|
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
|
|
G |
Nts |
neurotensin |
decreases response to substance |
EXP |
NTS protein results in decreased susceptibility to Phenylephrine |
CTD |
PMID:2326505 |
|
NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
|
|
G |
Nup62 |
nucleoporin 62 |
multiple interactions decreases expression |
EXP |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Phenylephrine results in decreased expression of NUP62 protein]; leptomycin B inhibits the reaction [Phenylephrine results in decreased expression of NUP62 protein]; trichostatin A inhibits the reaction [Phenylephrine results in decreased expression of NUP62 protein] |
CTD |
PMID:25341891 |
|
NCBI chr 1:95,298,995...95,314,902
Ensembl chr 1:95,295,526...95,315,174
|
|
G |
Ogn |
osteoglycin |
decreases expression |
EXP |
Phenylephrine results in decreased expression of OGN mRNA |
CTD |
PMID:18158353 |
|
NCBI chr17:15,032,069...15,052,626
Ensembl chr17:15,032,069...15,052,739
|
|
G |
Oxt |
oxytocin/neurophysin I prepropeptide |
multiple interactions increases secretion |
EXP |
Adenosine Triphosphate promotes the reaction [Phenylephrine results in increased secretion of OXT protein]; pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [[Phenylephrine co-treated with Adenosine Triphosphate] results in increased secretion of OXT protein] |
CTD |
PMID:11102496 PMID:15149956 |
|
NCBI chr 3:117,782,650...117,783,490
Ensembl chr 3:117,782,650...117,783,490
|
|
G |
P2rx5 |
purinergic receptor P2X 5 |
increases expression |
EXP |
Phenylephrine results in increased expression of P2RX5 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr10:57,777,737...57,789,426
Ensembl chr10:57,777,819...57,789,423
|
|
G |
P4ha1 |
prolyl 4-hydroxylase subunit alpha 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of P4HA1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr20:27,302,046...27,352,098
Ensembl chr20:27,302,141...27,352,786
|
|
G |
Pacc1 |
proton activated chloride channel 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of PACC1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr13:102,904,668...102,929,770
Ensembl chr13:102,894,612...102,929,770
|
|
G |
Pafah1b1 |
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 |
multiple interactions |
EXP |
Phenylephrine inhibits the reaction [Iodine-131 inhibits the reaction [PAFAH1B1 protein binds to ATXN1 protein]]; Phenylephrine inhibits the reaction [Iodine-131 inhibits the reaction [PAFAH1B1 protein binds to SOX2 protein]]; Phenylephrine inhibits the reaction [Iodine-131 results in decreased expression of PAFAH1B1 protein] |
CTD |
PMID:32278511 |
|
NCBI chr10:59,533,042...59,591,808
Ensembl chr10:59,534,117...59,591,808
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
EXP |
Phenylephrine inhibits the reaction [Oxygen deficiency results in increased cleavage of PARP1 protein] |
CTD |
PMID:11042672 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Parva |
parvin, alpha |
affects localization |
EXP |
Phenylephrine affects the localization of PARVA protein |
CTD |
PMID:16170337 |
|
NCBI chr 1:166,547,142...166,704,958
Ensembl chr 1:166,547,132...166,704,950
|
|
G |
Pcna |
proliferating cell nuclear antigen |
increases expression multiple interactions |
EXP |
Phenylephrine results in increased expression of PCNA protein Phenylephrine promotes the reaction [Iodine-131 results in increased expression of PCNA protein] |
CTD |
PMID:15603588 PMID:32278511 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pcp4 |
Purkinje cell protein 4 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of PCP4 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr11:35,759,711...35,861,725
Ensembl chr11:35,800,713...35,861,725
|
|
G |
Pcsk6 |
proprotein convertase subtilisin/kexin type 6 |
increases expression |
EXP |
Phenylephrine results in increased expression of PCSK6 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:119,428,978...119,627,626
Ensembl chr 1:119,429,265...119,627,596
|
|
G |
Pde1a |
phosphodiesterase 1A |
multiple interactions |
EXP |
PDE1A protein promotes the reaction [Phenylephrine results in decreased activity of PRKG1 protein] |
CTD |
PMID:19797176 |
|
NCBI chr 3:64,745,140...65,025,178
Ensembl chr 3:64,747,269...65,024,874
|
|
G |
Pde4b |
phosphodiesterase 4B |
increases expression |
EXP |
Phenylephrine results in increased expression of PDE4B mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:116,799,819...117,369,155
Ensembl chr 5:116,799,971...117,367,696
|
|
G |
Pde5a |
phosphodiesterase 5A |
multiple interactions |
EXP |
PDE5A protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; PDE5A protein affects the reaction [Phenylephrine results in increased expression of NPPB mRNA] |
CTD |
PMID:18790048 |
|
NCBI chr 2:210,858,515...211,003,480
Ensembl chr 2:210,858,063...210,999,701
|
|
G |
Pdk2 |
pyruvate dehydrogenase kinase 2 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of PDK2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr10:79,972,550...79,987,074
Ensembl chr10:79,972,556...79,987,085
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase 4 |
multiple interactions decreases expression |
EXP |
4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid inhibits the reaction [Phenylephrine results in decreased expression of PDK4 mRNA]; parthenolide inhibits the reaction [Phenylephrine results in decreased expression of PDK4 mRNA] |
CTD |
PMID:15721863 PMID:15728586 |
|
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
|
|
G |
Pdlim3 |
PDZ and LIM domain 3 |
increases expression |
EXP |
Phenylephrine results in increased expression of PDLIM3 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr16:46,352,460...46,383,680
Ensembl chr16:46,352,467...46,383,657
|
|
G |
Pea15 |
proliferation and apoptosis adaptor protein 15 |
increases expression |
EXP |
Phenylephrine results in increased expression of PEA15 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr13:84,657,815...84,667,437
Ensembl chr13:84,654,870...84,667,499
|
|
G |
Per1 |
period circadian regulator 1 |
multiple interactions |
ISO |
U 0126 inhibits the reaction [Phenylephrine results in increased expression of PER1 mRNA] |
CTD |
PMID:12729908 |
|
NCBI chr10:53,800,126...53,814,963
Ensembl chr10:53,805,535...53,814,431
|
|
G |
Per2 |
period circadian regulator 2 |
multiple interactions |
ISO |
U 0126 inhibits the reaction [Phenylephrine results in increased expression of PER2 mRNA] |
CTD |
PMID:12729908 |
|
NCBI chr 9:92,007,289...92,049,551
Ensembl chr 9:92,007,296...92,049,459
|
|
G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
decreases expression |
EXP |
Phenylephrine results in decreased expression of PEX11A mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:133,680,091...133,687,172
Ensembl chr 1:133,680,091...133,687,172
|
|
G |
Pfkl |
phosphofructokinase, liver type |
increases expression |
EXP |
Phenylephrine results in increased expression of PFKL mRNA |
CTD |
PMID:18158353 |
|
NCBI chr20:10,664,285...10,686,324
Ensembl chr20:10,664,272...10,686,315
|
|
G |
Phgdh |
phosphoglycerate dehydrogenase |
increases expression |
EXP |
Phenylephrine results in increased expression of PHGDH mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
|
|
G |
Phlda1 |
pleckstrin homology-like domain, family A, member 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of PHLDA1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
|
|
G |
Pkd1 |
polycystin 1, transient receptor potential channel interacting |
affects response to substance |
ISO |
PKD1 protein affects the susceptibility to Phenylephrine |
CTD |
PMID:18679710 |
|
NCBI chr10:13,573,779...13,621,138
Ensembl chr10:13,573,021...13,621,128
|
|
G |
Pklr |
pyruvate kinase L/R |
multiple interactions decreases activity |
EXP |
Calcium inhibits the reaction [Phenylephrine results in decreased activity of PKLR protein] |
CTD |
PMID:747652 |
|
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
|
|
G |
Pkp4 |
plakophilin 4 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of PKP4 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 3:43,632,364...43,835,834
Ensembl chr 3:43,631,880...43,835,474
|
|
G |
Pla2g2a |
phospholipase A2 group IIA |
decreases expression |
EXP |
Phenylephrine results in decreased expression of PLA2G2A mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:151,076,442...151,079,019
Ensembl chr 5:151,076,442...151,079,014
|
|
G |
Pla2g6 |
phospholipase A2 group VI |
affects response to substance |
EXP |
PLA2G6 protein affects the susceptibility to Phenylephrine |
CTD |
PMID:17885217 |
|
NCBI chr 7:110,851,378...110,891,557
Ensembl chr 7:110,851,378...110,891,114
|
|
G |
Plaat1 |
phospholipase A and acyltransferase 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of PLAAT1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr11:71,517,492...71,537,142
Ensembl chr11:71,517,493...71,527,020
|
|
G |
Plcb1 |
phospholipase C beta 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of PLCB1 mRNA |
CTD |
PMID:16714034 |
|
NCBI chr 3:122,059,988...122,772,896
Ensembl chr 3:122,060,031...122,772,869
|
|
G |
Plcb3 |
phospholipase C beta 3 |
increases expression |
EXP |
Phenylephrine results in increased expression of PLCB3 mRNA |
CTD |
PMID:16714034 |
|
NCBI chr 1:204,143,257...204,160,384
Ensembl chr 1:204,144,956...204,160,228
|
|
G |
Plcd1 |
phospholipase C, delta 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of PLCD1 mRNA |
CTD |
PMID:16714034 |
|
NCBI chr 8:118,795,196...118,818,186
Ensembl chr 8:118,795,201...118,818,186
|
|
G |
Plcg1 |
phospholipase C, gamma 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of PLCG1 mRNA |
CTD |
PMID:16714034 |
|
NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330
|
|
G |
Pomc |
proopiomelanocortin |
multiple interactions increases secretion increases response to substance |
EXP ISO |
Indomethacin inhibits the reaction [Phenylephrine results in increased secretion of POMC protein alternative form] POMC protein results in increased susceptibility to Phenylephrine |
CTD |
PMID:2822310 PMID:3015460 PMID:10898105 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions decreases expression |
EXP |
[pirinixic acid binds to PPARA protein] inhibits the reaction [Phenylephrine results in increased activity of RELA protein]; [pirinixic acid binds to PPARA protein] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; [pirinixic acid binds to PPARA protein] inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA]; AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of PPARA mRNA]; AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of PPARA protein] Phenylephrine results in decreased expression of PPARA mRNA; Phenylephrine results in decreased expression of PPARA protein |
CTD |
PMID:18701451 PMID:19699196 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
multiple interactions |
EXP |
[4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid results in increased activity of PPARD protein] which results in decreased susceptibility to Phenylephrine; [GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased activity of RELA protein]; [GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; [GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA] |
CTD |
PMID:15721863 PMID:18701451 |
|
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
|
|
G |
Ppp1r12a |
protein phosphatase 1, regulatory subunit 12A |
multiple interactions increases phosphorylation |
EXP |
geranylgeraniol inhibits the reaction [Simvastatin inhibits the reaction [Phenylephrine results in increased phosphorylation of PPP1R12A protein]]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Phenylephrine results in increased phosphorylation of PPP1R12A protein]; Phenylephrine promotes the reaction [RHOA protein results in increased phosphorylation of PPP1R12A protein]; polydatin inhibits the reaction [Phenylephrine results in increased phosphorylation of PPP1R12A protein]; Simvastatin inhibits the reaction [Phenylephrine promotes the reaction [RHOA protein results in increased phosphorylation of PPP1R12A protein]]; Simvastatin inhibits the reaction [Phenylephrine results in increased phosphorylation of PPP1R12A protein]; Y 27632 inhibits the reaction [Phenylephrine results in increased phosphorylation of PPP1R12A protein] |
CTD |
PMID:24449418 PMID:25449040 |
|
NCBI chr 7:43,482,808...43,593,689
Ensembl chr 7:43,482,803...43,593,425
|
|
G |
Ppp1r14a |
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
multiple interactions increases phosphorylation |
EXP |
geranylgeraniol inhibits the reaction [Simvastatin inhibits the reaction [Phenylephrine results in increased phosphorylation of PPP1R14A protein]]; Phenylephrine promotes the reaction [RHOA protein results in increased phosphorylation of PPP1R14A protein]; Simvastatin inhibits the reaction [Phenylephrine promotes the reaction [RHOA protein results in increased phosphorylation of PPP1R14A protein]]; Simvastatin inhibits the reaction [Phenylephrine results in increased phosphorylation of PPP1R14A protein] |
CTD |
PMID:24449418 |
|
NCBI chr 1:84,583,127...84,590,743
Ensembl chr 1:84,586,627...84,590,671
|
|
G |
Ppp3cb |
protein phosphatase 3 catalytic subunit beta |
increases expression multiple interactions increases activity |
ISO EXP |
Phenylephrine results in increased expression of PPP3CB mRNA CABIN1 protein inhibits the reaction [Phenylephrine results in increased activity of PPP3CB protein] Phenylephrine results in increased expression of PPP3CB mRNA; Phenylephrine results in increased expression of PPP3CB protein |
CTD |
PMID:10655507 PMID:16024800 |
|
NCBI chr15:3,759,950...3,804,976
Ensembl chr15:3,760,030...3,804,981
|
|
G |
Prkca |
protein kinase C, alpha |
multiple interactions increases localization increases activity increases expression |
ISO EXP |
DGKE protein inhibits the reaction [Phenylephrine results in increased localization of PRKCA protein]; Diglycerides affects the reaction [Phenylephrine results in increased localization of PRKCA protein] Phenylephrine results in increased activity of PRKCA protein GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of PRKCA protein]; paricalcitol inhibits the reaction [Phenylephrine results in increased expression of PRKCA protein modified form]; Phenylephrine results in increased phosphorylation of and results in increased activity of PRKCA protein |
CTD |
PMID:12435817 PMID:16809552 PMID:18487437 PMID:21565836 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Prkcb |
protein kinase C, beta |
multiple interactions increases expression |
EXP |
Phenylephrine promotes the reaction [RBCK1 protein binds to PRKCB protein]; RBCK1 protein inhibits the reaction [Phenylephrine results in increased expression of PRKCB protein] |
CTD |
PMID:17121852 |
|
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
|
|
G |
Prkcd |
protein kinase C, delta |
increases expression affects localization |
EXP |
Phenylephrine results in increased expression of PRKCD protein Phenylephrine affects the localization of PRKCD protein |
CTD |
PMID:12720544 |
|
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
|
|
G |
Prkce |
protein kinase C, epsilon |
multiple interactions affects localization increases localization increases expression |
ISO EXP |
DGKE protein inhibits the reaction [Phenylephrine results in increased localization of PRKCE protein]; Diglycerides affects the reaction [Phenylephrine results in increased localization of PRKCE protein] Phenylephrine affects the localization of PRKCE protein [chelerythrine results in decreased activity of PRKCE protein] which results in decreased susceptibility to Phenylephrine; GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of PRKCE protein]; Phenylephrine results in increased phosphorylation of and results in increased activity of PRKCE protein Phenylephrine results in increased expression of PRKCE protein |
CTD |
PMID:12003851 PMID:12700091 PMID:12720544 PMID:16809552 PMID:18487437 |
|
NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
|
|
G |
Prkcz |
protein kinase C, zeta |
affects localization multiple interactions decreases activity increases phosphorylation |
EXP |
Phenylephrine affects the localization of PRKCZ protein GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of PRKCZ protein]; Phenylephrine results in increased phosphorylation of and results in increased activity of PRKCZ protein; PRKCZ protein affects the reaction [Phenylephrine results in increased expression of AGT mRNA]; PRKCZ protein affects the reaction [Phenylephrine results in increased expression of FOS mRNA]; PRKCZ protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; PRKCZ protein affects the reaction [Phenylephrine results in increased expression of NPPB mRNA]; PRKCZ protein affects the reaction [Phenylephrine results in increased phosphorylation of and affects the localization of STAT3 protein] Phenylephrine results in decreased activity of PRKCZ protein Phenylephrine results in increased phosphorylation of PRKCZ protein |
CTD |
PMID:14736339 PMID:16809552 PMID:27094369 |
|
NCBI chr 5:165,817,786...165,930,386
Ensembl chr 5:165,819,466...165,930,367
|
|
G |
Prkd1 |
protein kinase D1 |
affects localization increases activity multiple interactions increases phosphorylation |
ISO EXP |
Phenylephrine affects the localization of PRKD1 protein Phenylephrine results in increased activity of PRKD1 protein [Phenylephrine results in increased activity of PRKD1 protein] which affects the localization of HDAC5 protein Phenylephrine increases phosphorylation of Prkd1 protein in neonatal ventricular myocytes |
CTD RGD |
PMID:19124542 PMID:16648482 |
RGD:243065275 |
NCBI chr 6:67,725,193...68,039,002
Ensembl chr 6:67,725,905...68,039,042
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
multiple interactions decreases activity increases activity increases expression |
EXP |
[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; [Phenylephrine co-treated with Copper] results in increased activity of PRKG1 protein; [S-Nitroso-N-Acetylpenicillamine co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; FLT1 protein promotes the reaction [Phenylephrine results in increased activity of PRKG1 protein]; PDE1A protein promotes the reaction [Phenylephrine results in decreased activity of PRKG1 protein]; Phenylephrine inhibits the reaction [Cyclosporine results in increased expression of PRKG1 mRNA]; Phenylephrine inhibits the reaction [Cyclosporine results in increased expression of PRKG1 protein]; VIM mutant form inhibits the reaction [[Copper co-treated with Phenylephrine] results in increased activity of PRKG1 protein]; VIM mutant form inhibits the reaction [Phenylephrine results in increased activity of PRKG1 protein] Phenylephrine results in increased expression of PRKG1 protein |
CTD |
PMID:11799084 PMID:16378109 PMID:19542178 PMID:19797176 PMID:26168186 |
|
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
|
|
G |
Procr |
protein C receptor |
increases expression |
EXP |
Phenylephrine results in increased expression of PROCR mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 3:144,254,596...144,258,863
Ensembl chr 3:144,254,380...144,258,903
|
|
G |
Psph |
phosphoserine phosphatase |
increases expression |
EXP |
Phenylephrine results in increased expression of PSPH mRNA |
CTD |
PMID:18158353 |
|
NCBI chr12:26,882,524...26,905,084
Ensembl chr12:26,883,133...26,905,074
|
|
G |
Ptgis |
prostaglandin I2 synthase |
increases expression |
EXP |
Phenylephrine results in increased expression of PTGIS mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
multiple interactions affects response to substance |
ISO |
FBN1 protein affects the reaction [PTGS1 protein affects the susceptibility to Phenylephrine] |
CTD |
PMID:17641673 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
EXP |
Losartan inhibits the reaction [Phenylephrine results in increased expression of PTGS2 mRNA]; Losartan inhibits the reaction [Phenylephrine results in increased expression of PTGS2 protein] |
CTD |
PMID:17244722 PMID:18701451 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pthlh |
parathyroid hormone-like hormone |
increases expression multiple interactions |
EXP |
Phenylephrine results in increased expression of PTHLH mRNA; Phenylephrine results in increased expression of PTHLH protein PTHLH protein affects the reaction [Phenylephrine results in decreased expression of BAX protein]; PTHLH protein affects the reaction [Phenylephrine results in increased expression of BCL2 mRNA]; PTHLH protein affects the reaction [Phenylephrine results in increased expression of BCL2 protein]; PTHLH protein affects the reaction [Phenylephrine results in increased expression of TIMP1 mRNA]; PTHLH protein affects the reaction [Phenylephrine results in increased expression of TIMP1 protein] |
CTD |
PMID:19910689 |
|
NCBI chr 4:180,188,792...180,199,847
Ensembl chr 4:180,188,792...180,199,847
|
|
G |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
decreases expression |
EXP |
Phenylephrine results in decreased expression of PTPRF mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:131,741,959...131,824,000
Ensembl chr 5:131,742,754...131,810,023
|
|
G |
Ptprk |
protein tyrosine phosphatase, receptor type, K |
decreases expression |
EXP |
Phenylephrine results in decreased expression of PTPRK mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:16,738,896...17,236,687
Ensembl chr 1:16,850,576...17,103,605
|
|
G |
Pvr |
PVR cell adhesion molecule |
increases expression |
EXP |
Phenylephrine results in increased expression of PVR mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:79,561,294...79,576,700
Ensembl chr 1:79,546,879...79,576,715
|
|
G |
Pycard |
PYD and CARD domain containing |
decreases expression |
EXP |
Phenylephrine results in decreased expression of PYCARD mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Pygl |
glycogen phosphorylase L |
multiple interactions increases expression |
EXP |
[Phenylephrine co-treated with Calcium] results in increased activity of PYGL protein; Glucose inhibits the reaction [[Phenylephrine co-treated with Calcium] results in increased activity of PYGL protein] Phenylephrine results in increased expression of PYGL mRNA |
CTD |
PMID:747652 PMID:18158353 |
|
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
|
|
G |
Rab3b |
RAB3B, member RAS oncogene family |
decreases expression |
EXP |
Phenylephrine results in decreased expression of RAB3B mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:123,629,562...123,697,410
Ensembl chr 5:123,644,423...123,697,401
|
|
G |
Rac1 |
Rac family small GTPase 1 |
increases activity |
EXP |
Phenylephrine results in increased activity of RAC1 protein |
CTD |
PMID:11158304 |
|
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
multiple interactions increases phosphorylation |
EXP |
Docosahexaenoic Acids inhibits the reaction [Phenylephrine results in increased phosphorylation of RAF1 protein] |
CTD |
PMID:15258898 |
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Rai14 |
retinoic acid induced 14 |
increases expression |
EXP |
Phenylephrine results in increased expression of RAI14 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 2:59,546,284...59,682,687
Ensembl chr 2:59,546,284...59,681,971
|
|
G |
Ramp1 |
receptor activity modifying protein 1 |
affects expression |
EXP |
Phenylephrine affects the expression of RAMP1 mRNA |
CTD |
PMID:17250927 |
|
NCBI chr 9:91,765,481...91,816,152
Ensembl chr 9:91,781,285...91,816,151
|
|
G |
Ramp2 |
receptor activity modifying protein 2 |
multiple interactions decreases expression increases expression |
EXP |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of RAMP2 mRNA Phenylephrine results in decreased expression of RAMP2 mRNA Phenylephrine results in increased expression of RAMP2 mRNA |
CTD |
PMID:12899678 PMID:17250927 |
|
NCBI chr10:86,187,366...86,190,692
Ensembl chr10:86,188,812...86,231,829
|
|
G |
Ramp3 |
receptor activity modifying protein 3 |
increases expression |
EXP |
Phenylephrine results in increased expression of RAMP3 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr14:81,527,404...81,544,905
Ensembl chr14:81,527,385...81,544,902
|
|
G |
Ranbp1 |
RAN binding protein 1 |
multiple interactions |
EXP |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Phenylephrine affects the localization of and affects the expression of RANBP1 protein]; leptomycin B inhibits the reaction [Phenylephrine affects the localization of and affects the expression of RANBP1 protein]; Phenylephrine affects the localization of and affects the expression of RANBP1 protein; trichostatin A inhibits the reaction [Phenylephrine affects the localization of and affects the expression of RANBP1 protein] |
CTD |
PMID:25341891 |
|
NCBI chr11:82,742,603...82,750,836
Ensembl chr11:82,742,600...82,750,838
|
|
G |
Rapgef4 |
Rap guanine nucleotide exchange factor 4 |
increases expression |
EXP |
Phenylephrine results in increased expression of RAPGEF4 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 3:56,809,388...57,101,332
Ensembl chr 3:56,809,270...57,102,316
|
|
G |
Rapsn |
receptor-associated protein of the synapse |
decreases expression |
EXP |
Phenylephrine results in decreased expression of RAPSN mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 3:77,015,073...77,024,378
Ensembl chr 3:76,983,471...77,024,373
|
|
G |
Rasd2 |
RASD family, member 2 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of RASD2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr19:13,594,291...13,605,016
Ensembl chr19:13,594,291...13,605,016
|
|
G |
Rassf1 |
Ras association domain family member 1 |
decreases response to substance |
ISO EXP |
RASSF1 protein results in decreased susceptibility to Phenylephrine |
CTD |
PMID:19652091 |
|
NCBI chr 8:108,225,023...108,236,164
Ensembl chr 8:108,225,023...108,236,164
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
increases expression affects phosphorylation |
EXP |
Phenylephrine results in increased expression of RB1 protein Phenylephrine affects the phosphorylation of RB1 protein |
CTD |
PMID:15603588 PMID:18084315 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rbck1 |
RANBP2-type and C3HC4-type zinc finger containing 1 |
multiple interactions affects response to substance |
EXP |
Phenylephrine promotes the reaction [RBCK1 protein binds to PRKCB protein]; Phenylephrine results in increased phosphorylation of and results in increased expression of RBCK1 protein; RBCK1 protein inhibits the reaction [Phenylephrine results in increased expression of PRKCB protein] RBCK1 protein affects the susceptibility to Phenylephrine |
CTD |
PMID:17121852 |
|
NCBI chr 3:140,789,079...140,806,017
Ensembl chr 3:140,789,080...140,806,005
|
|
G |
Rbfox2 |
RNA binding fox-1 homolog 2 |
|
EXP |
Phenylephrine increases expression of Rbfox2 mRNA and protein in vascular smooth muscle cells |
RGD |
PMID:28993448 |
RGD:329848961 |
NCBI chr 7:108,810,627...109,054,420
Ensembl chr 7:108,810,628...109,054,691
|
|
G |
Rcan1 |
regulator of calcineurin 1 |
increases expression multiple interactions |
ISO EXP |
Phenylephrine results in increased expression of RCAN1 protein MYOZ2 protein inhibits the reaction [Phenylephrine results in increased expression of RCAN1 protein] Phenylephrine results in increased expression of RCAN1 mRNA |
CTD |
PMID:18025526 PMID:25358972 |
|
NCBI chr11:31,622,208...31,702,150
Ensembl chr11:31,622,210...31,702,045
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions affects localization increases activity |
EXP |
[GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased activity of RELA protein]; [pirinixic acid binds to PPARA protein] inhibits the reaction [Phenylephrine results in increased activity of RELA protein] Phenylephrine affects the localization of RELA protein |
CTD |
PMID:11381115 PMID:18701451 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ren |
renin |
decreases activity affects response to substance |
ISO |
Phenylephrine results in decreased activity of REN protein REN1 protein affects the susceptibility to Phenylephrine |
CTD |
PMID:2847676 PMID:17679040 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Rev3l |
REV3 like, DNA directed polymerase zeta catalytic subunit |
decreases expression |
EXP |
Phenylephrine results in decreased expression of REV3L mRNA |
CTD |
PMID:18158353 |
|
NCBI chr20:43,131,841...43,290,102
Ensembl chr20:43,132,363...43,290,099
|
|
G |
Rgs2 |
regulator of G-protein signaling 2 |
multiple interactions affects response to substance increases expression |
EXP ISO |
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of RGS2 mRNA]; 2-Chloroadenosine inhibits the reaction [Phenylephrine results in increased expression of RGS2 mRNA]; N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of RGS2 mRNA]; N(6)-cyclopentyladenosine inhibits the reaction [Phenylephrine results in increased expression of RGS2 mRNA]; RGS2 protein inhibits the reaction [Phenylephrine results in increased expression of ACTA1 mRNA]; RGS2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; RGS2 protein inhibits the reaction [Phenylephrine results in increased expression of SLC9A1 mRNA]; RGS2 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; RGS2 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; RGS2 protein promotes the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK8 protein] RGS2 protein affects the susceptibility to Phenylephrine |
CTD |
PMID:15452191 PMID:16517124 PMID:17644703 PMID:18158353 |
|
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
|
|
G |
Rgs3 |
regulator of G-protein signaling 3 |
multiple interactions |
ISO |
RGS3 protein affects the reaction [[Timolol co-treated with Phenylephrine] results in increased phosphorylation of and results in increased activity of MAPK1 protein]; RGS3 protein affects the reaction [[Timolol co-treated with Phenylephrine] results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:18977218 |
|
NCBI chr 5:76,022,038...76,161,895
Ensembl chr 5:76,022,001...76,161,894
|
|
G |
Rgs4 |
regulator of G-protein signaling 4 |
multiple interactions |
ISO |
RGS4 protein affects the reaction [[Timolol co-treated with Phenylephrine] results in increased phosphorylation of and results in increased activity of MAPK1 protein]; RGS4 protein affects the reaction [[Timolol co-treated with Phenylephrine] results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:18977218 |
|
NCBI chr13:81,936,775...81,943,103
Ensembl chr13:81,936,775...81,943,068
|
|
G |
Rhoa |
ras homolog family member A |
multiple interactions increases activity |
EXP |
geranylgeraniol inhibits the reaction [Simvastatin inhibits the reaction [Phenylephrine results in increased activity of RHOA protein]]; monomethylarsonous acid promotes the reaction [Phenylephrine results in increased activity of RHOA protein]; Phenylephrine promotes the reaction [RHOA protein results in increased phosphorylation of PPP1R12A protein]; Phenylephrine promotes the reaction [RHOA protein results in increased phosphorylation of PPP1R14A protein]; polydatin inhibits the reaction [Phenylephrine results in increased activity of RHOA protein]; RHOA protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; Simvastatin inhibits the reaction [Phenylephrine promotes the reaction [RHOA protein results in increased phosphorylation of PPP1R12A protein]]; Simvastatin inhibits the reaction [Phenylephrine promotes the reaction [RHOA protein results in increased phosphorylation of PPP1R14A protein]]; Simvastatin inhibits the reaction [Phenylephrine results in increased activity of RHOA protein] |
CTD |
PMID:10843871 PMID:15081308 PMID:21708234 PMID:24449418 PMID:25449040 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Ripk1 |
receptor interacting serine/threonine kinase 1 |
increases expression |
ISO |
Phenylephrine results in increased expression of RIPK1 protein |
CTD |
PMID:31605733 |
|
NCBI chr17:30,839,639...30,871,824
Ensembl chr17:30,839,650...30,871,824
|
|
G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
increases expression |
ISO |
Phenylephrine results in increased expression of RIPK3 protein |
CTD |
PMID:31605733 |
|
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
|
|
G |
Rnd1 |
Rho family GTPase 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of RND1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399
|
|
G |
Rnf39 |
ring finger protein 39 |
increases expression |
EXP |
Phenylephrine results in increased expression of RNF39 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr20:1,604,794...1,610,283
Ensembl chr20:1,604,794...1,610,283
|
|
G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
increases expression |
EXP |
Phenylephrine results in increased expression of ROCK2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 6:39,679,116...39,774,033
Ensembl chr 6:39,679,082...39,774,031
|
|
G |
Rps6ka5 |
ribosomal protein S6 kinase A5 |
multiple interactions |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of RPS6KA5 protein]; Phenylephrine results in increased phosphorylation of and results in increased activity of RPS6KA5 protein; RPS6KA5 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of CREB1 protein]; RPS6KA5 protein promotes the reaction [Phenylephrine results in increased expression of JUN mRNA]; SB 203580 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of RPS6KA5 protein] |
CTD |
PMID:15522277 PMID:19002563 |
|
NCBI chr 6:119,828,823...120,006,190
Ensembl chr 6:119,828,846...120,006,224
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
multiple interactions increases phosphorylation |
EXP |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein]; [Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of RPS6KB1 protein; bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein]; Calcium affects the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of RPS6KB1 protein]; DUSP6 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of RPS6KB1 protein]; Ethanol inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of RPS6KB1 protein]; Phenylephrine results in increased phosphorylation of and results in increased activity of RPS6KB1 protein; Prazosin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein]; resveratrol inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of RPS6KB1 protein]; rottlerin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein]; SGK1 protein promotes the reaction [Phenylephrine results in increased phosphorylation of RPS6KB1 protein]; Sirolimus inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein]; U 0126 inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein] |
CTD |
PMID:12411397 PMID:12720544 PMID:12935885 PMID:15757502 PMID:15795328 PMID:18562309 More...
|
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Rps6kb2 |
ribosomal protein S6 kinase B2 |
multiple interactions |
EXP |
bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein]; Prazosin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein]; rottlerin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein] |
CTD |
PMID:12720544 |
|
NCBI chr 1:201,451,265...201,458,096
Ensembl chr 1:201,451,265...201,458,078
|
|
G |
Rrad |
RRAD, Ras related glycolysis inhibitor and calcium channel regulator |
decreases expression |
EXP |
Phenylephrine results in decreased expression of RRAD protein |
CTD |
PMID:18056528 |
|
NCBI chr19:354,184...357,424
Ensembl chr19:354,198...357,417
|
|
G |
Runx1t1 |
RUNX1 partner transcriptional co-repressor 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of RUNX1T1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:27,187,674...27,338,070
Ensembl chr 5:27,187,551...27,335,592
|
|
G |
S100a6 |
S100 calcium binding protein A6 |
multiple interactions |
EXP |
S100A6 protein inhibits the reaction [Phenylephrine results in increased expression of ACTA1 mRNA]; S100A6 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; S100A6 protein inhibits the reaction [Phenylephrine results in increased expression of S100B mRNA] |
CTD |
PMID:15652358 |
|
NCBI chr 2:176,100,619...176,102,181
Ensembl chr 2:176,100,899...176,102,180
|
|
G |
S100b |
S100 calcium binding protein B |
increases expression multiple interactions |
EXP |
Phenylephrine results in increased expression of S100B mRNA S100A6 protein inhibits the reaction [Phenylephrine results in increased expression of S100B mRNA]; S100B protein inhibits the reaction [Phenylephrine results in increased expression of ACTA1 mRNA]; S100B protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA] |
CTD |
PMID:15652358 |
|
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
Sc5d |
sterol-C5-desaturase |
increases expression |
EXP |
Phenylephrine results in increased expression of SC5D mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
|
|
G |
Scd2 |
stearoyl-Coenzyme A desaturase 2 |
increases expression |
EXP |
Phenylephrine results in increased expression of SCD2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:243,169,171...243,182,231
Ensembl chr 1:243,169,236...243,182,232
|
|
G |
Selenbp1 |
selenium binding protein 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of SELENBP1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594
|
|
G |
Sema6d |
semaphorin 6D |
decreases expression |
EXP |
Phenylephrine results in decreased expression of SEMA6D mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 3:111,883,415...111,941,100
Ensembl chr 3:111,883,872...111,941,094
|
|
G |
Septin5 |
septin 5 |
increases expression |
EXP |
Phenylephrine results in increased expression of SEPTIN5 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr11:82,373,601...82,379,393
Ensembl chr11:82,369,754...82,379,393
|
|
G |
Serpine1 |
serpin family E member 1 |
increases expression |
ISO EXP |
Phenylephrine results in increased expression of SERPINE1 mRNA |
CTD |
PMID:15808835 PMID:15850565 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
increases phosphorylation multiple interactions |
EXP |
Phenylephrine results in increased phosphorylation of SGK1 protein Phenylephrine promotes the reaction [Cortisone results in increased expression of SGK1 mRNA]; SGK1 protein promotes the reaction [Phenylephrine results in increased phosphorylation of GSK3B protein]; SGK1 protein promotes the reaction [Phenylephrine results in increased phosphorylation of RPS6KB1 protein]; SGK1 protein promotes the reaction [Phenylephrine results in increased phosphorylation of TSC2 protein] |
CTD |
PMID:15795328 PMID:16533503 |
|
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
|
|
G |
Sik1 |
salt-inducible kinase 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of SIK1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr20:9,949,407...9,959,036
Ensembl chr20:9,947,396...9,958,991
|
|
G |
Sirt6 |
sirtuin 6 |
multiple interactions |
EXP |
[SIRT6 protein co-treated with EP300 protein] affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; [SIRT6 protein co-treated with EP300 protein] affects the reaction [Phenylephrine results in increased expression of NPPB mRNA]; Phenylephrine results in decreased expression of and results in decreased activity of SIRT6 protein; SIRT6 protein affects the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; SIRT6 protein inhibits the reaction [Phenylephrine results in increased expression of EP300 protein]; SIRT6 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; SIRT6 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; SIRT6 protein inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA] |
CTD |
PMID:27094368 |
|
NCBI chr 7:8,082,312...8,087,776
Ensembl chr 7:8,082,364...8,098,914
|
|
G |
Slc12a2 |
solute carrier family 12 member 2 |
multiple interactions |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine promotes the reaction [SLC12A2 protein results in increased uptake of Rubidium]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased phosphorylation of SLC12A2 protein]; Phenylephrine promotes the reaction [SLC12A2 protein results in increased uptake of Rubidium] |
CTD |
PMID:14630635 |
|
NCBI chr18:51,348,282...51,416,448
Ensembl chr18:51,348,302...51,416,440
|
|
G |
Slc16a10 |
solute carrier family 16 member 10 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of SLC16A10 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr20:43,454,819...43,567,839
Ensembl chr20:43,459,709...43,567,839
|
|
G |
Slc16a3 |
solute carrier family 16 member 3 |
increases expression |
EXP |
Phenylephrine results in increased expression of SLC16A3 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr10:106,212,679...106,222,564
Ensembl chr10:106,212,778...106,222,562
|
|
G |
Slc16a7 |
solute carrier family 16 member 7 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of SLC16A7 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 7:61,043,667...61,211,547
Ensembl chr 7:61,051,167...61,154,994
|
|
G |
Slc1a3 |
solute carrier family 1 member 3 |
increases expression |
EXP |
Phenylephrine results in increased expression of SLC1A3 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 2:57,755,495...57,830,605
Ensembl chr 2:57,755,497...57,830,605
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
multiple interactions |
EXP |
[Quinidine analog results in decreased activity of SLC22A1 protein] which results in decreased import of Phenylephrine |
CTD |
PMID:21140131 |
|
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
|
|
G |
Slc22a3 |
solute carrier family 22 member 3 |
multiple interactions |
EXP |
[Corticosterone results in decreased activity of SLC22A3 protein] which results in decreased import of Phenylephrine |
CTD |
PMID:21140131 |
|
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
|
|
G |
Slc26a6 |
solute carrier family 26 member 6 |
decreases activity increases expression |
EXP |
Phenylephrine results in decreased activity of SLC26A6 protein Phenylephrine results in increased expression of SLC26A6 protein |
CTD |
PMID:17124262 |
|
NCBI chr 8:109,558,968...109,569,778
Ensembl chr 8:109,559,642...109,569,778
|
|
G |
Slc29a1 |
solute carrier family 29 member 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of SLC29A1 mRNA |
CTD |
PMID:19966059 |
|
NCBI chr 9:15,399,661...15,414,203
Ensembl chr 9:15,399,612...15,414,203
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of SLC2A1 mRNA |
CTD |
PMID:15808844 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc4a1ap |
solute carrier family 4 member 1 adaptor protein |
decreases expression |
EXP |
Phenylephrine results in decreased expression of SLC4A1AP mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 6:24,905,941...24,933,651
Ensembl chr 6:24,905,941...24,933,815
|
|
G |
Slc4a3 |
solute carrier family 4 member 3 |
increases activity |
EXP |
Phenylephrine results in increased activity of SLC4A3 protein |
CTD |
PMID:17124262 |
|
NCBI chr 9:77,036,243...77,053,940
Ensembl chr 9:77,037,016...77,049,105
|
|
G |
Slc7a1 |
solute carrier family 7 member 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of SLC7A1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849
|
|
G |
Slc8a1 |
solute carrier family 8 member A1 |
multiple interactions decreases expression increases expression |
ISO EXP |
EGR1 protein affects the reaction [[Isoproterenol co-treated with Phenylephrine] results in increased expression of SLC8A1 mRNA]; EGR1 protein affects the reaction [[Isoproterenol co-treated with Phenylephrine] results in increased expression of SLC8A1 protein]; Propranolol inhibits the reaction [[Isoproterenol co-treated with Phenylephrine] results in increased expression of SLC8A1 protein] Phenylephrine results in decreased expression of SLC8A1 protein Phenylephrine results in increased expression of SLC8A1 mRNA |
CTD |
PMID:11179087 PMID:15621046 PMID:19244478 |
|
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
|
|
G |
Slc9a1 |
solute carrier family 9 member A1 |
multiple interactions increases activity increases expression |
EXP |
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of SLC9A1 protein]; 3-methylsulfonyl-4-piperidinobenzoyl guanidine inhibits the reaction [[Phenylephrine results in increased activity of SLC9A1 protein] which results in increased transport of Calcium]; [[Phenylephrine results in increased activity of SLC9A1 protein] which results in increased transport of Calcium] which results in increased expression of ATP2A2 protein; [Phenylephrine results in increased activity of SLC9A1 protein] which results in increased transport of Calcium; N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of SLC9A1 protein]; N(6)-cyclopentyladenosine inhibits the reaction [Phenylephrine results in increased expression of SLC9A1 protein]; RGS2 protein inhibits the reaction [Phenylephrine results in increased expression of SLC9A1 mRNA]; SLC9A1 protein promotes the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; SLC9A1 protein promotes the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein] Phenylephrine results in increased expression of SLC9A1 mRNA; Phenylephrine results in increased expression of SLC9A1 protein |
CTD |
PMID:15452191 PMID:16236312 PMID:16513848 PMID:16517124 |
|
NCBI chr 5:145,576,341...145,629,630
Ensembl chr 5:145,576,334...145,629,624
|
|
G |
Smad2 |
SMAD family member 2 |
multiple interactions |
EXP |
Phenylephrine results in increased phosphorylation of and results in increased localization of and results in increased activity of SMAD2 protein |
CTD |
PMID:19443575 |
|
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
|
|
G |
Smoc2 |
SPARC related modular calcium binding 2 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of SMOC2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:55,262,472...55,391,804
Ensembl chr 1:55,262,530...55,391,693
|
|
G |
Smr3b |
submaxillary gland androgen regulated protein 3B |
multiple interactions |
EXP |
SMR3B protein promotes the reaction [NPPC protein affects the susceptibility to Phenylephrine] |
CTD |
PMID:17026587 |
|
NCBI chr14:19,783,815...19,788,557
Ensembl chr14:19,783,816...19,788,492
|
|
G |
Sord |
sorbitol dehydrogenase |
decreases expression |
EXP |
Phenylephrine results in decreased expression of SORD mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
multiple interactions |
EXP |
Phenylephrine inhibits the reaction [Iodine-131 inhibits the reaction [PAFAH1B1 protein binds to SOX2 protein]] |
CTD |
PMID:32278511 |
|
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
|
|
G |
Sox6 |
SRY-box transcription factor 6 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of SOX6 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:169,723,306...170,334,846
Ensembl chr 1:169,729,194...170,277,386
|
|
G |
Sp1 |
Sp1 transcription factor |
multiple interactions |
ISO |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of SP1 mRNA; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of SP1 mRNA] |
CTD |
PMID:10710348 |
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of SPP1 protein |
CTD |
PMID:10406839 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Spry1 |
sprouty RTK signaling antagonist 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of SPRY1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 2:120,557,256...120,561,917
Ensembl chr 2:120,556,706...120,566,189
|
|
G |
Spta1 |
spectrin, alpha, erythrocytic 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of SPTA1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr13:86,203,504...86,279,371
Ensembl chr13:86,203,504...86,279,371
|
|
G |
Sqle |
squalene epoxidase |
increases expression |
EXP |
Phenylephrine results in increased expression of SQLE mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
|
|
G |
Sqstm1 |
sequestosome 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of SQSTM1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
St3gal2 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
increases expression |
EXP |
Phenylephrine results in increased expression of ST3GAL2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr19:38,888,851...38,939,874
Ensembl chr19:38,923,999...38,939,869
|
|
G |
St3gal4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
increases expression |
EXP |
Phenylephrine results in increased expression of ST3GAL4 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 8:33,415,666...33,465,319
Ensembl chr 8:33,415,671...33,524,389
|
|
G |
St8sia5 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 |
increases expression |
EXP |
Phenylephrine results in increased expression of ST8SIA5 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr18:70,736,395...70,802,537
Ensembl chr18:70,736,602...70,797,789
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of STAT1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
affects localization multiple interactions increases expression |
EXP |
Phenylephrine affects the localization of STAT3 protein Cyclosporine inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased expression of STAT3 protein]; Phenylephrine results in increased phosphorylation of and affects the localization of STAT3 protein; Phenylephrine results in increased phosphorylation of and results in increased expression of STAT3 protein; PRKCZ protein affects the reaction [Phenylephrine results in increased phosphorylation of and affects the localization of STAT3 protein]; Verapamil inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased expression of STAT3 protein] Phenylephrine results in increased expression of STAT3 |
CTD |
PMID:19299911 PMID:27094369 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stc1 |
stanniocalcin 1 |
affects expression |
EXP |
Phenylephrine affects the expression of STC1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
|
|
G |
Stmn1 |
stathmin 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of STMN1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
|
|
G |
Stx11 |
syntaxin 11 |
affects expression |
EXP |
Phenylephrine affects the expression of STX11 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:7,293,427...7,320,060
Ensembl chr 1:7,289,976...7,320,164
|
|
G |
Tac1 |
tachykinin, precursor 1 |
multiple interactions affects response to substance increases secretion |
EXP |
alfuzosin inhibits the reaction [Phenylephrine results in increased secretion of TAC1 protein] TAC1 protein affects the susceptibility to Phenylephrine |
CTD |
PMID:11270094 PMID:17240043 |
|
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
|
|
G |
Tacr1 |
tachykinin receptor 1 |
increases response to substance |
EXP |
TACR1 protein results in increased susceptibility to Phenylephrine |
CTD |
PMID:16982039 |
|
NCBI chr 4:114,920,844...115,089,733
Ensembl chr 4:114,920,844...115,089,733
|
|
G |
Taf1 |
TATA-box binding protein associated factor 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of TAF1 mRNA |
CTD |
PMID:15808844 |
|
NCBI chr X:66,640,915...66,716,543
Ensembl chr X:66,640,982...66,716,543
|
|
G |
Tcte1 |
t-complex-associated testis expressed 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of TCTE1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 9:15,463,573...15,482,258
Ensembl chr 9:15,463,739...15,472,954
|
|
G |
Tfdp1 |
transcription factor Dp-1 |
increases expression |
EXP |
Phenylephrine results in increased expression of TFDP1 protein |
CTD |
PMID:12682052 |
|
NCBI chr16:76,162,040...76,200,871
Ensembl chr16:76,162,043...76,200,817
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
increases expression |
ISO EXP |
Phenylephrine results in increased expression of TGFB1 mRNA Phenylephrine results in increased expression of TGFB1 mRNA; Phenylephrine results in increased expression of TGFB1 protein |
CTD |
PMID:10406839 PMID:11821714 PMID:19443575 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb1i1 |
transforming growth factor beta 1 induced transcript 1 |
increases expression multiple interactions |
EXP |
Phenylephrine results in increased expression of TGFB1I1 protein [Phenylephrine results in increased phosphorylation of MAPK1 protein] which affects the expression of TGFB1I1 protein; [Phenylephrine results in increased phosphorylation of MAPK3 protein] which affects the expression of TGFB1I1 protein; TGFB1I1 protein promotes the reaction [Phenylephrine results in increased expression of ACTA1 mRNA]; TGFB1I1 protein promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA]; TGFB1I1 protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein] |
CTD |
PMID:19540241 |
|
NCBI chr 1:182,828,553...182,835,465
Ensembl chr 1:182,828,544...182,837,080
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
increases expression |
EXP |
Phenylephrine results in increased expression of TGFB2 mRNA |
CTD |
PMID:19443575 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Tgfb3 |
transforming growth factor, beta 3 |
increases expression |
EXP |
Phenylephrine results in increased expression of TGFB3 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
|
|
G |
Tgfbr1 |
transforming growth factor, beta receptor 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of TGFBR1 mRNA |
CTD |
PMID:19443575 |
|
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
increases expression |
EXP |
Phenylephrine results in increased expression of TGFBR2 mRNA |
CTD |
PMID:19443575 |
|
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
|
|
G |
Tgm2 |
transglutaminase 2 |
multiple interactions increases expression decreases activity |
EXP |
ADRA1B protein affects the reaction [Phenylephrine results in decreased activity of TGM2 protein]; Ethanol inhibits the reaction [Phenylephrine results in decreased activity of TGM2 protein] Phenylephrine results in increased expression of TGM2 mRNA |
CTD |
PMID:10801782 PMID:18158353 |
|
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
|
|
G |
Thra |
thyroid hormone receptor alpha |
multiple interactions increases expression |
EXP |
THRA protein affects the reaction [Phenylephrine results in decreased expression of MYH6 protein] Phenylephrine results in increased expression of THRA protein |
CTD |
PMID:11577024 PMID:17389455 |
|
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
|
|
G |
Thrb |
thyroid hormone receptor beta |
decreases expression multiple interactions increases expression |
EXP |
Phenylephrine results in decreased expression of THRB mRNA; Phenylephrine results in decreased expression of THRB protein THRB protein affects the reaction [Phenylephrine results in decreased expression of ATP2A2 protein]; THRB protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 protein]; Triiodothyronine inhibits the reaction [Phenylephrine results in decreased expression of THRB mRNA]; Triiodothyronine inhibits the reaction [Phenylephrine results in decreased expression of THRB protein] Phenylephrine results in increased expression of THRB protein |
CTD |
PMID:11577024 PMID:17389455 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions increases expression |
EXP |
BCL2 protein affects the reaction [Phenylephrine results in increased expression of TIMP1 protein]; PTHLH protein affects the reaction [Phenylephrine results in increased expression of TIMP1 mRNA]; PTHLH protein affects the reaction [Phenylephrine results in increased expression of TIMP1 protein] Phenylephrine results in increased expression of TIMP1 mRNA; Phenylephrine results in increased expression of TIMP1 protein |
CTD |
PMID:18158353 PMID:19910689 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tmem140 |
transmembrane protein 140 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of TMEM140 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 4:63,536,477...63,547,478
Ensembl chr 4:63,536,168...63,548,455
|
|
G |
Tmem176b |
transmembrane protein 176B |
decreases expression |
EXP |
Phenylephrine results in decreased expression of TMEM176B mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 4:77,766,928...77,774,740
Ensembl chr 4:77,766,928...77,774,384
|
|
G |
Tmem43 |
transmembrane protein 43 |
increases expression |
EXP |
Phenylephrine results in increased expression of TMEM43 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 4:123,977,680...123,992,823
Ensembl chr 4:123,977,625...123,992,825
|
|
G |
Tmsb15b2 |
thymosin beta 15B2 |
increases expression |
EXP |
Phenylephrine results in increased expression of TMSB15B2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr X:100,298,705...100,300,820
Ensembl chr X:100,298,514...100,300,886
|
|
G |
Tnf |
tumor necrosis factor |
decreases secretion multiple interactions increases expression decreases response to substance |
EXP |
Phenylephrine results in decreased secretion of TNF protein Phenylephrine promotes the reaction [FOXO1 protein results in increased expression of TNF mRNA]; Pilocarpine inhibits the reaction [Phenylephrine results in increased expression of TNF protein] Phenylephrine results in increased expression of TNF mRNA; Phenylephrine results in increased expression of TNF protein TNF protein results in decreased susceptibility to Phenylephrine |
CTD |
PMID:12423672 PMID:13679239 PMID:16020479 PMID:17872965 PMID:18701451 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
increases expression |
ISO |
Phenylephrine results in increased expression of TNFAIP3 protein |
CTD |
PMID:12900338 |
|
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tnfrsf12a |
TNF receptor superfamily member 12A |
increases expression |
EXP |
Phenylephrine results in increased expression of TNFRSF12A mRNA |
CTD |
PMID:18158353 |
|
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
increases expression multiple interactions |
ISO |
Phenylephrine results in increased expression of TNFSF11 mRNA 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased expression of TNFSF11 mRNA]; bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased expression of TNFSF11 mRNA]; Prazosin inhibits the reaction [Phenylephrine results in increased expression of TNFSF11 mRNA] |
CTD |
PMID:17306214 |
|
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
|
|
G |
Tox |
thymocyte selection-associated high mobility group box |
decreases expression |
EXP |
Phenylephrine results in decreased expression of TOX mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:19,874,994...20,171,272
Ensembl chr 5:19,874,467...20,171,272
|
|
G |
Tpm2 |
tropomyosin 2 |
increases expression |
EXP |
Phenylephrine results in increased expression of TPM2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:57,770,919...57,780,278
Ensembl chr 5:57,770,864...57,779,992
|
|
G |
Trdn |
triadin |
decreases expression |
EXP |
Phenylephrine results in decreased expression of TRDN mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:23,955,651...24,410,494
Ensembl chr 1:23,955,651...24,410,595
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
increases expression |
EXP |
Phenylephrine results in increased expression of TRIB3 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Trim2 |
tripartite motif-containing 2 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of TRIM2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 2:169,500,628...169,652,855
Ensembl chr 2:169,500,634...169,652,927
|
|
G |
Trim25 |
tripartite motif-containing 25 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of TRIM25 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr10:73,812,818...73,831,271
Ensembl chr10:73,812,818...73,831,257
|
|
G |
Trim34 |
tripartite motif-containing 34 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of TRIM34 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 1:158,707,172...158,720,214
Ensembl chr 1:158,707,172...158,718,674
|
|
G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of TRPC1 protein |
CTD |
PMID:17174323 |
|
NCBI chr 8:96,263,322...96,314,220
Ensembl chr 8:96,263,329...96,314,276
|
|
G |
Trpc3 |
transient receptor potential cation channel, subfamily C, member 3 |
multiple interactions increases expression |
EXP |
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [[Phenylephrine results in increased expression of TRPC3 protein] which results in increased transport of Calcium]; [Phenylephrine results in increased expression of TRPC3 protein] which results in increased transport of Calcium; TRPC3 protein promotes the reaction [Phenylephrine results in increased transport of Calcium] Phenylephrine results in increased expression of TRPC3 mRNA; Phenylephrine results in increased expression of TRPC3 protein |
CTD |
PMID:15672411 PMID:19244478 |
|
NCBI chr 2:119,481,313...119,619,333
Ensembl chr 2:119,481,400...119,558,855
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
multiple interactions |
EXP |
TRPC6 protein promotes the reaction [Phenylephrine results in increased transport of Calcium] |
CTD |
PMID:15672411 |
|
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
|
|
G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
multiple interactions |
EXP |
6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one inhibits the reaction [icilin inhibits the reaction [Phenylephrine results in increased activity of TRPM8 protein]]; 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one inhibits the reaction [Menthol inhibits the reaction [Phenylephrine results in increased activity of TRPM8 protein]]; capsazepine inhibits the reaction [Phenylephrine results in increased activity of TRPM8 protein]; icilin inhibits the reaction [Phenylephrine results in increased activity of TRPM8 protein]; Menthol inhibits the reaction [Phenylephrine results in increased activity of TRPM8 protein]; N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide inhibits the reaction [Phenylephrine results in increased activity of TRPM8 protein]; Phenanthrolines inhibits the reaction [Phenylephrine results in increased activity of TRPM8 protein]; Phenylephrine binds to and results in increased activity of TRPM8 protein |
CTD |
PMID:19363131 |
|
NCBI chr 9:88,897,039...88,990,167
Ensembl chr 9:88,903,880...88,988,552
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
multiple interactions |
ISO |
TRPV1 protein affects the susceptibility to [Phenylephrine co-treated with calcitonin gene-related peptide (8-37)]; TRPV1 protein affects the susceptibility to [Phenylephrine co-treated with capsazepine] |
CTD |
PMID:17082722 |
|
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
|
|
G |
Tsc2 |
TSC complex subunit 2 |
multiple interactions increases phosphorylation |
EXP |
SGK1 protein promotes the reaction [Phenylephrine results in increased phosphorylation of TSC2 protein]; U 0126 inhibits the reaction [Phenylephrine results in increased phosphorylation of TSC2 protein] |
CTD |
PMID:15757502 PMID:15795328 |
|
NCBI chr10:13,621,135...13,655,773
Ensembl chr10:13,621,136...13,655,951
|
|
G |
Tubb6 |
tubulin, beta 6 class V |
increases expression |
EXP |
Phenylephrine results in increased expression of TUBB6 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr18:60,943,394...60,953,031
Ensembl chr18:60,943,375...60,954,418
|
|
G |
Tymp |
thymidine phosphorylase |
multiple interactions decreases expression |
EXP |
VEGFA protein inhibits the reaction [Phenylephrine results in decreased expression of SCO2 protein] |
CTD |
PMID:25107896 |
|
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
|
|
G |
Tyr |
tyrosinase |
multiple interactions increases activity |
EXP |
Dactinomycin inhibits the reaction [Phenylephrine results in increased activity of TYR protein]; Prazosin inhibits the reaction [Phenylephrine results in increased activity of TYR protein] |
CTD |
PMID:15278367 |
|
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
|
|
G |
Ubn1 |
ubinuclein 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of UBN1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr10:10,496,576...10,532,010
Ensembl chr10:10,496,576...10,532,010
|
|
G |
Uchl1 |
ubiquitin C-terminal hydrolase L1 |
increases expression |
EXP |
Phenylephrine results in increased expression of UCHL1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590
|
|
G |
Ucn |
urocortin |
affects response to substance |
EXP |
UCN protein affects the susceptibility to Phenylephrine |
CTD |
PMID:17885217 |
|
NCBI chr 6:25,238,120...25,238,950
Ensembl chr 6:25,238,120...25,238,950
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of VCAM1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vcan |
versican |
increases expression |
EXP |
Phenylephrine results in increased expression of VCAN mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 2:20,761,718...20,860,637
Ensembl chr 2:20,761,718...20,860,637
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
EXP |
VEGFA protein inhibits the reaction [Phenylephrine results in decreased abundance of Copper]; VEGFA protein inhibits the reaction [Phenylephrine results in decreased expression of COX11 protein]; VEGFA protein inhibits the reaction [Phenylephrine results in decreased expression of COX17 protein]; VEGFA protein inhibits the reaction [Phenylephrine results in decreased expression of SCO2 protein] |
CTD |
PMID:25107896 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vim |
vimentin |
increases expression multiple interactions |
EXP |
Phenylephrine results in increased expression of VIM protein VIM mutant form inhibits the reaction [[Copper co-treated with Phenylephrine] results in increased activity of PRKG1 protein]; VIM mutant form inhibits the reaction [Phenylephrine results in increased activity of PRKG1 protein] |
CTD |
PMID:26168186 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Vip |
vasoactive intestinal peptide |
affects response to substance |
ISO |
VIP protein affects the susceptibility to Phenylephrine |
CTD |
PMID:11728430 |
|
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
|
|
G |
Wasl |
WASP like actin nucleation promoting factor |
multiple interactions |
EXP |
ABL1 protein affects the reaction [Phenylephrine promotes the reaction [CRK protein binds to WASL protein]] |
CTD |
PMID:17615370 |
|
NCBI chr 4:53,083,536...53,132,061
Ensembl chr 4:53,083,536...53,132,022
|
|
G |
Wfdc1 |
WAP four-disulfide core domain 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of WFDC1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr19:47,720,191...47,739,121
Ensembl chr19:47,720,423...47,739,108
|
|
G |
Wif1 |
Wnt inhibitory factor 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of WIF1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 7:56,548,060...56,618,364
Ensembl chr 7:56,548,053...56,618,360
|
|
G |
Xpr1 |
xenotropic and polytropic retrovirus receptor 1 |
increases expression |
EXP |
Phenylephrine results in increased expression of XPR1 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr13:67,441,205...67,585,950
Ensembl chr13:67,446,380...67,585,946
|
|
G |
Zdhhc2 |
zinc finger DHHC-type palmitoyltransferase 2 |
increases expression |
EXP |
Phenylephrine results in increased expression of ZDHHC2 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr16:51,808,465...51,878,060
Ensembl chr16:51,808,468...51,878,060
|
|
G |
Zfp46 |
zinc finger protein 46 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of ZFP46 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr 5:148,519,398...148,529,903
Ensembl chr 5:148,520,855...148,529,459
|
|
G |
Zfp503 |
zinc finger protein 503 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of ZFP503 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr15:2,313,060...2,316,848
Ensembl chr15:2,313,060...2,316,848
|
|
G |
Zfp866 |
zinc finger protein 866 |
decreases expression |
EXP |
Phenylephrine results in decreased expression of CXCL5 mRNA |
CTD |
PMID:18158353 |
|
NCBI chr16:19,653,966...19,675,968
Ensembl chr16:19,668,258...19,675,932
|
|
G |
Zfpm2 |
zinc finger protein, multitype 2 |
decreases response to substance multiple interactions |
ISO EXP |
ZFPM2 protein results in decreased susceptibility to Phenylephrine ZFPM2 protein inhibits the reaction [Phenylephrine promotes the reaction [GATA4 protein binds to EP300 protein]]; ZFPM2 protein inhibits the reaction [Phenylephrine results in increased activity of GATA4 protein]; ZFPM2 protein inhibits the reaction [Phenylephrine results in increased expression of EDN1 mRNA]; ZFPM2 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; ZFPM2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] |
CTD |
PMID:15220332 |
|
NCBI chr 7:71,678,658...72,116,209
Ensembl chr 7:71,678,880...72,116,205
|
|